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 monocytes are an important myeloid-derived subset of innate immune cells. They are 
known to contribute to the restriction of infections as well as to immunopathology by 
phagocytosis, cytokine production and differentiation into specialized subpopulations. Recent 
groundbreaking studies have suggested that Ly6C
hi
 monocytes also play protective roles, e. g. 
during recovery from spinal cord injury. 
The goal of this thesis was to investigate the contribution of Ly6C
hi
 monocytes in homeostatic 
and pathophysiological processes of the central nervous system. In the first part of the results, 
we found that Ly6C
hi
 monocytes link both changes in the intestinal flora upon antibiotic or 
probiotic treatment and physical exercise to altered neurogenesis levels in a murine model. 
Moreover, their genetically-induced or antibody-dependent absence reduces neurogenesis and 
substitution of Ly6C
hi
 monocytes can restore reduced neurogenesis levels due to antibiotic-
treatment. 
In the second part, we provide evidence that Ly6C
hi
 monocytes are able to take up β-amyloid 
in an ex vivo phagocytosis assay and that their enhanced presence upon chronic experimental 
Toxoplasma gondii infection leads to reduced plaque disposal in the brain of 5xFAD mice. As 
soluble β-amyloid levels are also reduced upon monocyte infiltration and Ly6Chi monocytes 
are not located in the direct vicinity of plaques, we conclude that Ly6C
hi
 monocytes prevent 
plaque formation by uptake of biochemical precursors. 
Taken together, our results demonstrate that Ly6C
hi
 monocytes promote the maintenance of 
hippocampal neurogenesis as well as clearance of waste products during neurodegenerative 
diseases. Thus, this study supports a refined and more balanced picture of this essential 
immune cell population. 
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 monocytes are a fundamental element of the innate immune response. In the following 
thesis, I will demonstrate how this cell subset contributes to maintain physiological levels of 
adult hippocampal neurogenesis in mice and the mechanism of reduction of β-amyloidosis 
using an experimental model for Alzheimer’s disease. 
1.1 Immune System 
With more than 9×10
29
 microbes on our planet and countless other pathogens including 
viruses, protozoan, and parasites, the integrity of our body is continuously challenged from 
outside. Moreover, mutated cells loom on the inside and many physiological processes leave 
behind potentially hazardous residues. Resolving these danger signals requires an elaborate 
protective system which is guard, soldier and cleaner all at once: the immune system. 
Within the vertebrate body, three main levels of protection can be found. First, surface 
barriers prevent attachment and entrance of pathogens. The second line of defense is provided 
by innate immune cells, which sense damage or pathogens via pattern recognition receptors. 
Third, highly specific cells of the adaptive immunity precisely target and fight individual 
pathogens via recombined high-affinity receptors (Delves & Roitt 2000). 
1.1.1 Innate Immunity 
The innate immune system is evolutionary older than adaptive immunity and can be found not 
only in vertebrates but also in plants, fungi, insects and primitive multicellular organisms. 
Recognition and response by the innate immune system are carried out in a generic manner 
and do not result in long-lasting protection (Delves & Roitt 2000). Both humoral and cellular 
components are part of the innate immunity (Parkin & Cohen 2001). 
The humoral branch consists of complement and contact cascade, naturally occurring 
antibodies and pentraxins. Through opsonization and activation of phagocytes, these elements 
facilitate an effective early response to pathogens and cell debris (Shishido et al. 2012). 
The cellular compartment of the innate immune system includes a variety of cells with diverse 
functions. Long-lived mast cells exert their major function during Immunoglobulin E (IgE)-
mediated responses e. g. against helminths and are involved in inflammatory responses to 
allergens along with basophils and eosinophils (Voehringer 2013). 
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Moreover, there are several types of phagocytic cells: monocytes, macrophages and their 
respective tissue-specific counterparts, neutrophils, and dendritic cells (DCs). 
Monocytes and their function will be described in detail in chapter 1.1.2. 
Macrophages are tissue resident phagocytes equipped with many different pattern recognition 
receptors. Harnessing these receptors, macrophages contribute to tissue homeostasis, 
effectively remove apoptotic cells, and can also recognize and phagocytose pathogens 
(Gordon 2002). Depending on their environment, macrophages can secrete different effector 
molecules including growth factors and cytokines (Arango Duque & Descoteaux 2014). 
Highly specialized macrophage subsets are specifically located in certain tissues, including 
Kupffer cells in the liver, microglia in the brain and osteoclasts in the bone (Davies et al. 
2013). 
Neutrophils are rapidly recruited to sites of inflammation, rendering them crucial contributors 
to early acute stages of infections and injury. Neutrophil functions cover intra- and 
extracellular killing of parasites, phagocytosis as well as secretory activity (Kolaczkowska & 
Kubes 2013). 
Classical DCs are short-lived cells with a high phagocytic and migratory potential. After 
taking up antigens at the site of infection, they travel to lymphoid organs where they activate 
T cells (Geissmann et al. 2010; Merad et al. 2013). That way, DCs provide a link between 
innate and adaptive immunity. 
Besides the long-known cell types mentioned above, there is another group of innate cells 
which has been recently reported as innate lymphoid cells (ILCs). ILCs form a family of 
multifunctional cells including the previously described natural killer cells and are located 
primarily at barrier surfaces (Diefenbach et al. 2014). Interestingly, the three subpopulations 
of ILCs display striking similarities with adaptive T helper cell subsets, in particular with 
respect to their cytokine secretion: ILC1 play a role during immunity against intracellular 
infections by producing interferon γ (IFN-γ); with interleukin 13 (IL-13), ILC2 contribute 
substantially to the defense against extracellular multicellular parasites; and ILC3 lead the 
response to extracellular bacteria and fungi via secretion of IL-22. In addition to their 
contributions to acute immune responses, ILCs help to eventually resolve inflammation 




Monocytes originate in the bone marrow and develop from macrophage/DC precursors. They 
are subsequently released into the blood stream in a CCR2-dependent manner (Serbina & 
Pamer 2006). In the blood, monocytes can be divided into two main subsets according to their 
expression of certain surface molecules: CX3CR1
low CCR2+ Ly6Chigh and CX3CR1high CCR2-
 Ly6C- monocytes (Geissmann et al. 2003). 
Monocytes exert a double function: First, they are important immune effector cells. Second, 
they can develop into macrophages and inflammatory DCs, depending on the inflammatory 
conditions (Geissmann et al. 2010). 
As effector cells, monocytes produce cytokines and take up debris similar to other innate 
immune effectors (Geissmann et al. 2010). Under steady-state conditions, Ly6C
-
 monocytes 
patrol blood vessels by crawling along the luminal side of the endothelium, ready to 
extravasate quickly following an infection (Auffray et al. 2007; Auffray et al. 2009). During 
Figure 1.1: Monocyte heterogeneity upon defense against protozoan parasites. 





monocytes exit from the bone marrow into the blood in a CCR2-dependent manner. After migrating to tissue 
sites, Ly6C
hi
 monocytes can convert into monocyte derived DCs, monocyte derived macrophages and other 
subtypes. Importantly, Ly6C
hi
 monocytes can also directly phagocytose microbial pathogens. (Figure from 
Sheel & Engwerda 2012). 
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infection or tissue damage, inflammatory Ly6C
high
 monocytes migrate to the site of 
inflammation and produce high levels of TNF and IL-1 (Karlmark et al. 2012). 
As precursors, Ly6C
high
 monocytes differentiate into Ly6C
int
 DCs and Ly6C
low
 macrophages 
stimulated by the respective microenvironment. This functional monocyte heterogeneity 
provides a plastic immune response during the different stages of an inflammation and has 
been described in several experimental models (Gordon & Taylor 2005; Zigmond et al. 2012; 
Tacke & Zimmermann 2014; Sheel & Engwerda 2012). 
The role of monocytes in certain infections including Toxoplasma (T.) gondii, Plasmodium 
spp., Listeria monocytogenes and Influenza virus has been studied intensively.  
During acute infection with the protozoan parasite T. gondii, Ly6Chi monocytes in the small 
intestine are vital cells to ensure the survival of mice (Dunay et al. 2008; Dunay et al. 2010). 
Even at later stages when the infection has reached the brain, Ly6C
hi
 monocytes are 
indispensable for parasite control (Biswas et al. 2015). 
Plasmodium spp. are close relatives of T. gondii and cause malaria in humans and mice. 
Monocytes and monocyte-derived macrophages contribute to parasite control by 
phagocytosis, antibody-dependent cell inhibition as well as regulation of cytokine regulation 
(reviewed in Chua et al. 2013). Concurrently, they are involved in immunopathology 
including occlusion of small blood vessels in the brain during cerebral malaria (reviewed in 
Chua et al. 2013). 
Ly6C
hi
 monocytes are also required for resistance against bacterial infections such as Listeria 
monocytogenes (Serbina et al. 2003). In contrast, monocyte derived cells aggravate the 
disease by causing severe immunopathology in the central nervous system (CNS) during West 
Nile Virus encephalitis (Getts et al. 2008). 
In addition to their substantial role during infectious diseases, monocytes and their progeny 
are involved in other inflammatory processes such as liver fibrosis, muscle and spinal cord 
injury. 
Chronic inflammation of the liver caused by alcoholism or infections leads to liver fibrosis. 
This disease stage is characterized by abundant collagen deposition which inhibits normal 
liver function. Ablation of CCR2
+
 monocytes reduces fibrosis (Karlmark et al. 2009) and 
increased recruitment enhances it (Karlmark et al. 2010), both pointing out the disease 
promoting capacity of monocytes. Adding to the diverse functions of monocytes, they also 
contribute to the resolution of collagen deposition under the same conditions of liver fibrosis 
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by differentiating into macrophages and producing matrix metalloproteinases (MMPs) (Tacke 
& Zimmermann 2014). 
After muscle injury, monocytes give rise to macrophages supporting muscle regeneration 
(Arnold et al. 2007). Similarly, infiltrating monocyte-derived macrophages promote tissue 
repair following spinal cord injury (Shechter et al. 2009). 
In conclusion, monocytes can promote as well as resolve inflammation, depending on the 
context. Therefore the manipulation of monocytes may provide a powerful tool to develop 
new therapeutic strategies (Shechter & Schwartz 2013). 
1.1.3 Phagocytosis 
As mentioned above, the innate immune system includes different types of phagocytic cells. 
The term ‘phagocytosis’ is derived from the Ancient Greek words φαγεῖν (phagein; to 
devour), κύτος (kytos; cell), and –osis (process) and describes the active uptake of a particle 
from the environment by a cell. The uptake of any particle is initiated by binding to cell 
surface receptors. This specific binding sets phagocytosis apart from macropinocytosis, 
during which extracellular material is taken up randomly. Recognition of a target particle sets 
off multiple signaling cascades concomitantly which ultimately lead to the formation of a 
vesicle containing the particle, a phagosome. While the phagosome undergoes several 
maturation steps, its contents are eventually degraded (Flannagan et al. 2012; Underhill & 
Goodridge 2012). 
The unlimited range of particles which can be taken up by phagocytes includes small 
structures such as proteins as well as large ones like pathogens and apoptotic cells. 
Correspondingly, there are numerous receptors recognizing potential target particles, some of 
which are sufficient to induce phagocytosis while others require the collaboration with other 
molecules. Phagocytosis mediating receptors include pattern recognition receptors like toll 
like receptors (TLRs), antibody binding Fc receptors, Scavenger receptor A (e. g. SCARA1), 
CD36 and triggering receptor expressed on myeloid cells 2 (TREM2) (Flannagan et al. 2012; 
Lue et al. 2014). 
CD36 is a multiligand class B scavenger receptor which binds different targets like collagen, 
lipoproteins, fatty acids, and β-amyloid (Nergiz-Unal et al. 2011). At least some of these 
ligands can promote sterile inflammation by combined signaling of CD36 with a TLR4/TLR6 
heterodimer (Stewart et al. 2010). This mechanism provides a possible explanation why CD36 
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has been linked to diseases like atherosclerosis (Park 2014) and Alzheimer’s disease (El 
Khoury et al. 2003). 
TREM2 from the immunoglobulin superfamily is another receptor implicated in the initiation 
of phagocytosis (Lue et al. 2014). It recently attracted attention because of its possible 
involvement in Alzheimer’s disease (Guerreiro et al. 2013; Jonsson et al. 2013). Consistently, 
β-amyloid has been identified as a TREM2 ligand (Kleinberger et al. 2014). 
Functionally, phagocytosis is an essential part of the developing as well as the mature 
organism. During embryonic development, high numbers of apoptotic cells have to be 
removed. In mature organisms, phagocytosis is equally important to maintain tissue 
homeostasis and to clear the body from any kind of toxic molecules and debris, e. g. protein 
aggregates and pathogens. 
Impaired phagocytosis can lead to autoimmune diseases because apoptotic cells are not 
cleared appropriately (Poon et al. 2014) and may be, as the example of CD36 shows, involved 
in the development of multiple other diseases. 
1.2 Immunity of the central nervous system 
The spinal cord, optic nerve and brain form the CNS. The remaining nerve tracks in the body 
compose the peripheral, enteric and autonomic nervous systems. Similar to the situation in 
other tissues, in the CNS there are resident (glia) and recruited immune cells. Glia cells 
comprise mainly of oligodendrocytes, astrocytes and microglia (Purves et al. 2004). While the 
primary function of oligodendrocytes is to wrap the neuronal axons in myelin sheaths, 
astrocytes and microglia have significant immunological functions. 
1.2.1 Resident cells: astrocytes 
With respect to numbers, astrocytes are the second most prominent glia cell population in the 
CNS after oligodendrocytes. They are involved in the regulation of blood flow and synaptic 
activity as well as potassium, glutamate and water balance (Ransohoff & Brown 2012). 
Moreover, astrocytes express multiple immune receptors including TLRs, scavenger and 
complement receptors and can secrete cytokines, chemokines and neurotrophic factors. 
Mediators secreted by astrocytes upon stimulation include IL-6, IL-1β, TNF, TGF-β, 
chemokine C-C motif ligand 2 (CCL2), nerve growth factor (NGF) and brain derived 
neurotrophic factor (BDNF) (Farina et al. 2007). Equipped with this immunological toolbox, 
astrocytes can interact with innate and adaptive immunity and contribute to disease control as 
well as pathogenesis (Ransohoff & Brown 2012). Moreover, they can communicate with 
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microglia, the third most abundant glia cell and the major tissue resident immune player in the 
CNS. 
1.2.2 Resident cells: microglia 
Microglia belong to the myeloid lineage, yet they invade the neuroectoderm (which will later 
form the CNS) during embryogenesis before definitive hematopoiesis takes place (Ginhoux et 
al. 2010). In adult rodents microglia represent 5 to 12 % of CNS cells, depending on the 
region (Lawson et al. 1990). Microglia are phagocytic cells, removing debris as well as 
pruning synapses (Paolicelli et al. 2011). They express surface markers including CD45 
(remnant of their hematopoietic origin), CD11b (part of the complement receptor 3 and 
expressed on various leukocytes), ionized calcium-binding adaptor molecule 1 (Iba1, 
expressed exclusively on microglia and macrophages), and F4/80 (traditionally a pan-
macrophage marker), pointing towards their considerable immune functions (Saijo & Glass 
2011). Beyond that, their extremely broad range of receptors enables microglia to recognize 
neurotransmitters, neurohormones and -modulators, as well as danger- and pathogen-
associated patterns, cytokines and chemokines (Kettenmann et al. 2011). 
In the healthy brain, microglia display a ramified, highly plastic morphology. Stimulation of 
microglia by infection, tissue damage, and modified neuronal activity induces a motile, 
amoeboid “activated” phenotype (Kettenmann et al. 2011). These “activated microglia” are 
the source of chemokines and cytokines including IL-1β, IL-6, CCL2, and TNF to activate 
other cells in the vicinity and recruit further immune cells, but also immunoregulatory 
cytokines such as IL-10 (Hanisch 2002). Although microglia are more responsive to stimuli 
like bacterial lipopolysaccharide (LPS), the repertoire of cytokines and receptors shared 
between astrocytes and microglia can lead to a positive feedback loop and an abundant release 
of cytokines (Saijo & Glass 2011; Saijo et al. 2009). 
In recent years, the simplified portrayal of microglia as either “good” or “bad”, “resting” or 
“activated”, “friend” or “foe” has been continuously refined (Aguzzi et al. 2013). This will be 
described in more detail using the example of microglia in Alzheimer’s disease, see chapter 
1.4.3.1. 
With respect to terminology it is important to note that previously all phagocytic cells in the 
CNS were described as microglia. Recently, fate mapping studies allowed the discrimination 
between yolk sac-derived resident phagocytes (microglia) and bone marrow-derived recruited 
phagocytes (monocytes, macrophages and such) (Ginhoux et al. 2010). Subsequent 
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differentiation between resident and recruited brain macrophages revealed specific 
contributions of each subset under several pathological conditions (Schwartz & Baruch 2014). 
1.2.3 Recruited immune cells in the CNS 
As outlined above, innate immune cells continuously patrol the organism using lymphatic and 
circulatory vessels and thus, can rapidly detect and react to different kinds of disturbances. 
Notably, there are particular tissues which are excluded from this surveillance network: the 
immune privileged regions including the eye, the testis, the pregnant uterus, and the brain. All 
are vulnerable structures where damage can have devastating consequences like blindness, 
infertility, abortion, and cognitive impairments. Therefore, the immune privilege increases 
protection from both pathogen intrusion and collateral damage during immune responses 
(Arck et al. 2008). 
Immune privilege is maintained by a complex network of immunoregulatory and 
immunosuppressive processes and utilizes membrane-bound molecules such as Fas/FasL, 
soluble compounds including IL-10 and transforming growth factor β (TGF-β) secretion, and 
spatial separation (reviewed in Niederkorn 2006). 
In the brain, spatial separation is achieved by the combination of different barriers: the 
meninges, the blood-brain-barrier (BBB), and the blood-cerebrospinal-fluid-barrier (BCSFB). 
The meninges comprise of three membranes lining the outer surface of the CNS (Ransohoff & 
Engelhardt 2012). The BBB is established by adjacent endothelial cells which are stimulated 
mainly by signals from astrocytes and form increased numbers of tight junctions to limit 
paracellular transport and the transmigration of immune cells from the blood (Abbott et al. 
2006). In contrast, the BCSFB comprises of a fenestrated endothelium amended by a tight 
junction lined epithelium (Shechter et al. 2013).  
Under certain inflammatory circumstances, the BBB becomes leaky and foci of infiltrating 
immune cells from the blood can be found within the CNS. Amongst these infiltrating cells 
are monocytes, which display a similar functional heterogeneity as found in peripheral tissues. 
Different experimental paradigms have revealed three main subsets, distinguished by their 
surface expression of Ly6C: Ly6C
high
 monocytes invade the CNS, where they can further 
develop into Ly6C
int
 monocytes resembling DCs and Ly6C
low/-
 monocytes with macrophage 




In recent years, several interesting publications have added new layers to the concept of how 
the CNS is integrated into the overall immune system. A new model was promoted suggesting 
that when leukocytes enter through the BCSFB instead of through the BBB, they are 
modulated towards a regulatory phenotype beneficial for recovery from spinal cord injury 
(Shechter et al. 2013; Shechter et al. 2009). And with their remarkable discovery Louveau et 
al. revised the old dogma that the brain is exempted from lymphatic drainage (Louveau et al. 
2015). Finally, there is compelling evidence that immune cell recruitment and contribution is 
not restricted to inflammation but is instead an essential part of healthy physiology (Kipnis et 
al. 2004; Ziv et al. 2006; Schwartz et al. 2013). 
1.3 Role of monocytes in neurogenesis 
Looking at the CNS from an immunological point of view, glia cells often take the center 
stage. Nevertheless, the functional core of the CNS is formed by neuronal cells which develop 
from the neuroectoderm during embryogenesis (Liu & Niswander 2005). Neurogenesis, the 
process of generating functional neurons, was originally considered to occur only during 
embryogenesis (Ming & Song 2011). However, after the first descriptions of adult 
neurogenesis in the 1960s and 1980s (Altman & Das 1967; Paton & Nottebohm 1984), 
numerous studies revealed adult neurogenesis in almost all mammalian species including 
humans. Today, neurogenesis is acknowledged as a part of adult physiology (Kempermann et 
al. 1997; Eriksson et al. 1998; Kornack & Rakic 1999; Ming & Song 2011). 
1.3.1 Adult Neurogenesis 
Adult neurogenesis has mostly been described within two regions in the adult brain, the 
subventricular zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) in the 
dentate gyrus of the hippocampus. Neuroblasts generated in the SVZ migrate via the rostral 
migratory stream to the olfactory bulb, where they mature to interneurons. From the SGZ, 
neuroblasts travel only a short distance and develop into dentate granule neurons in the 
hippocampus (Ming & Song 2011). 
The hippocampus plays a crucial role in memory formation and spatial orientation (Fanselow 
& Dong 2010). However, the exact functions of adult neurogenesis in the SGZ of the 
hippocampus have not been elucidated yet. On the one hand, changes in (hippocampal) 
neurogenesis have been linked to different neurological diseases. These observations cannot 
give clear answers with respect to functionality, because the influence is most likely 
bidirectional (Ming & Song 2011). On the other hand, current animal research suggests that in 
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rodents only some hippocampus-dependent learning and memory tasks rely on the integration 
of new neurons during adulthood (Deng et al. 2010). 
Before their integration into the existing network, neurons undergo maturation. The different 
maturation stages are characterized by changes in morphology and protein expression, 
allowing their discrimination in immunohistological stainings. Neural precursors at the least 
differentiated stage, radial glia-like cells, express Nestin, which is later downregulated and 
replaced by doublecortin (Dcx) in neuroblasts (Ming & Song 2011). Adult, post-mitotic 
neurons can be identified by NeuN, a nuclear marker present on almost all neuronal cell types 
(Mullen et al. 1992). 
In adult humans, about 1400 new neurons are integrated into both dentate gyri every day 
(Spalding et al. 2013). Importantly, these surviving neurons are only a small proportion of the 
total number of newly generated neurons. Studies in mice have revealed that most of the 
newborn neurons die by apoptosis (Sierra et al. 2010). It is therefore important to discriminate 
between production and survival of newborn neurons. 
1.3.2 Immune system & neurogenesis 
A plethora of different factors have been identified to regulate adult neurogenesis including 
sex, aging, hormones, neurotransmitters, drugs, stress, diet or physical activity (reviewed in 
Ming & Song 2005). Both physiological and pathological stimuli influence adult neurogenesis 
in a complex manner. Multiple studies have shown that physical exercise and hippocampal 
dependent learning increase adult neurogenesis in the SGZ (van Praag et al. 1999; Ming & 
Song 2011; Mustroph et al. 2012). Injuries such as seizures and stroke also enhance adult 
neurogenesis, whereas chronic stress and inflammation both lead to a reduction (Ming & 
Song 2011). 
Accordingly, microglia derived inflammation inhibits neurogenesis after stimulation by 
irradiation (Monje et al. 2003), LPS or tissue damage (Ekdahl et al. 2003). Later it was found 
however, that microglia can also support neurogenesis, particularly after stimulation with IL-4 
or low levels of IFN-γ (Butovsky et al. 2006). Moreover, unchallenged microglia in the SGZ 
indirectly ensure proper neurogenesis by efficiently removing those newborn neurons which 
undergo apoptosis (Sierra et al. 2010). Interestingly, T cells have also been found to support 
neurogenesis (Ziv et al. 2006; Wolf et al. 2009). It is of note that only T cells recognizing the 
CNS located antigen myelin basic protein (MBP) were able to boost neurogenesis, but not 
those recognizing ovalbumin. This was reflected also in spatial memory and learning (Ziv et 
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al. 2006). A subsequent study specified that CD4
+
 but not CD8
+
 T cells are necessary to 
maintain neurogenesis levels (Wolf et al. 2009). 
The mechanisms by which immune cells influence neurogenesis are largely unknown, even 
though reduced BDNF levels were reported along with T cell depletion (Wolf et al. 2009). 
Additionally, the effect of selected immune mediators on neuronal proliferation, survival and 
differentiation is summarized in Table 1.1, proposing possible links between the immune 
system and neurogenesis. 
Table 1.1: Impact of selected immune mediators on neuronal proliferation, survival and differentiation. 
(Table adapted from Kohman & Rhodes 2013) 
 Proliferation Survival Neuronal differentiation 
IL-6 - - - 
IL-1β -  - 
TNF -  - 
TGF-β  + + 
IL-4   + 
IL-10 +   
1.3.3 Gut-Brain-Axis 
The increased recognition of homeostatic immune interactions between periphery and CNS 
(as described in chapters 1.2 and 1.3.2) brought on more questions: Which events in the 
periphery do influence the CNS milieu? How is this information from the periphery 
transmitted to the CNS? Which processes in the CNS are susceptible to immune modulation? 
1.3.3.1 Gut flora 
One of the factors proposed to influence the CNS milieu is the gut flora. It comprises bacteria, 
fungi, and viruses populating the luminal surface of the gut (Guarner & Malagelada 2003; 
Underhill & Iliev 2014; Cadwell 2015). Similarly, all other surfaces including skin, vaginal 
and upper respiratory tract are covered with microbes. The largest microbial community is 
located in the gut where it prevents the growth of invasive pathogens and helps with the 
digestion and uptake of nutrients (Guarner & Malagelada 2003). It has further been revealed 
that the gut flora is required for proper development of the immune system (Hooper et al. 
2012). 
Correspondingly, changes in the commensal gut flora have been associated with the 
susceptibility to diabetes, obesity (Tilg & Kaser 2011), inflammatory bowel disease (Wu et al. 
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2013), cancer, allergy and other diseases (Round & Mazmanian 2009). Alterations of the gut 
flora can also limit as well as exacerbate infections (Haag et al. 2012; Dicksved et al. 2014). 
Further, absence of gut microbiota impairs an effective antiviral response (Ichinohe et al. 
2011; Abt et al. 2012). 
The gut flora is not only highly diverse, but also differs from individual to individual 
(Eckburg et al. 2005). Nevertheless, certain trends can be observed, for example the shift from 
gram-negative Bacteroidetes towards gram-positive Firmicutes in obese mice and humans 
(Turnbaugh et al. 2006; Ley et al. 2006). 
1.3.3.2 Consequences for the CNS 
In addition to its effects on the immune system, the gut microbiota have been found to 
influence CNS-related disorders as well. This is reflected in several interesting findings. First, 
germ-free mice display reduced anxiety (Diaz Heijtz et al. 2011) and do not develop 
spontaneous autoimmune demyelination in the CNS (Berer et al. 2011). Second, depletion of 
the gut flora was proposed to alter microglia in the CNS and this altered phenotype can be 
reverted by short-chain fatty acid (SCFA) treatment (Erny et al. 2015). Third, the 
neurobehavioral changes accompanying obesity could be induced also by transferring an 
Figure 1.2: Communication 
pathways of the gut-brain-axis. 
ACTH, adrenocorticotropic 
hormone; CRF, corticotropin-
releasing factor; SCFAs, short-
chain fatty acids (Figure from 
Cryan & Dinan 2012). 
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obesity-like gut flora to non-obese mice (Bruce-Keller et al. 2015). Similarly, the visceral 
pain (or visceral hypersensitivity in animal models) associated with inflammatory bowel 
disease could be transferred by the gut flora alone (Crouzet et al. 2013). 
In line with these experimental results, human studies reported connections between microbial 
imbalance and psychiatric diseases including depression (Naseribafrouei et al. 2014) and 
autism (Parracho et al. 2005). 
1.3.3.3 Transmission of signals between gut and CNS 
There are multiple communication channels used to transmit information between the gut and 
the CNS, including neural, endocrinal and immune pathways (summarized in Figure 1.2) 
(Cryan & Dinan 2012). Neural communication can occur via the vagus nerve, providing a 
direct nervous connection between the enteric nervous system of the gut and the brain. 
Endocrinal signals include hormones whose release is triggered by the hypothalamus-
pituitary-adrenal axis. Classically, the immune system uses cytokines to exchange 
information, which can also act directly on the CNS (Cryan & Dinan 2012). Immune cells 
also have receptors for neuro-related molecules, e. g. cannabinoids (Croxford & Yamamura 
2005) making it a bidirectional communication. Other neuroactive mediators influenced by 
gut microbes include SCFAs and neurotransmitters, e. g. via tryptophan metabolism 
(reviewed in Cryan & Dinan 2012). Lastly, the gut microbes possibly translocate into the 
blood and form a dormant blood microbiome which could also interfere with immunity 
(Potgieter et al. 2015). 
1.3.4 Mouse models to study the gut-brain-axis 
The impact of the gut flora on aspects of physiology and pathology can be studied in different 
mouse models. Germ-free mice are transferred as embryos into sterile cages and are raised in 
absence of any microbiological flora. In contrast, gnotobiotic mice are raised under controlled 
specific pathogen free (SPF) conditions and the gut flora is later eradicated by admission of 
broad-spectrum antibiotics. The first model suffers from the high maintenance as well as 
developmental defects of the animals including an immature immune system (Mazmanian et 
al. 2005; Abt et al. 2012) and behavioral deficits (Diaz Heijtz et al. 2011; Cryan & Dinan 




1.4 Role of monocytes in Alzheimer’s disease 
Neurogenesis is, as described above, a physiological homeostatic process. In contrast, 
Alzheimer’s disease (AD) is a pathological condition of the CNS followed by 
neurodegeneration. 
1.4.1 Alzheimer’s disease 
With an estimated 24 million cases worldwide, dementia is a global health threat. Because the 
major risk factor for the onset of dementia is old age, patient numbers are predicted to rise, 
particularly in developed countries where demographics shift towards the elderly. With about 
70 %, the leading cause of dementia is AD (Reitz et al. 2011). AD is as neurodegenerative 
disorder and was first described more than 100 years ago by the German neuropathologist 
Alois Alzheimer (Alzheimer et al. 1991). 
The definite diagnosis of AD requires pathological evidence, in most cases post mortem. 
However, possible or probable AD can be diagnosed according to the gradual onset and 
aggravation of neuropsychiatric symptoms which cannot be explained by other causes (Reitz 
et al. 2011). 
The first clinical symptoms of AD include disturbances of short-term and episodic memory 
and loss of the ability to store new information, e. g. noticeable in displacement of every-day 
items. Subsequent decline in cognitive abilities is characterized by impairment of language, 
problem-solving, attention, mood, and long-term memory (Weintraub et al. 2012). Advanced 
and final stages of the disease usually require the patient’s hospitalization due to spatial and 
temporal disorientation, incontinence, and eventually the inability to perform even simple 
tasks without assistance. The cause of death is commonly not the disease itself but infections, 
e. g. pneumonia (Förstl & Kurz 1999). 
Despite extended and ongoing efforts in research, treatment options of AD are still poor. In 
the absence of a cure, treatment is carried out symptomatically and targets psychiatric 
symptoms as well as cognitive impairment. The latter is treated by inhibition of 
acetylcholinesterase and thereby slowing down the degradation of acetylcholine to antagonize 
the loss of cholinergic neurons. Additionally, neuronal loss through overstimulation can be 
fought by inhibiting the glutamatergic system (Lleó et al. 2006). 
Unfortunately, already lost cognitive functions cannot be restored. Moreover, the diagnosis of 
AD and with it the beginning of treatment is preceded by years or decades of “silent” 
pathogenesis (Saido & Iwata 2006). 
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The onset of disease usually takes place after 60 to 65 years of age in more than 95 % of AD 
cases, only in very rare (1-5 %) familial cases due to genetic mutations patients experience an 
early onset in their late 40s or early 50s (Reitz et al. 2011). Even though there is most likely 
some genetic contribution in sporadic cases, too, the biggest risk factor for developing AD is 
old age (Bekris et al. 2010). Additionally, systemic conditions including cerebrovascular 
disease, hypertension, and diabetes have been speculated to increase the risk for developing 
AD (Reitz et al. 2011). 
1.4.2 Pathogenesis of Alzheimer’s disease 
On the molecular level, the pathogenesis of AD is characterized by intracellular aggregation 
of hyperphosphorylated tau as neurofibrillary tangles and extracellular accumulation of β-
amyloid plaques (Braak & Braak 1991). 
Tau is a microtubule associated protein, which is found mostly in neurons. Abundant and 
abnormal phosphorylation leads to a loss of the microtubule stabilizing function and the 
Figure 1.3: Proteolytic cleavage of amyloid precursor protein (APP) by α-, β- and γ-secretases within the 
anti-amyloidogenic (left) and amyloidogenic (right) pathway. 
APP, amyloid precursor protein. CTF, carboxy-terminal fragment. AICD, APP intracellular domain. Aβ, β-amyloid. 
(Figure from Haass et al. 2012). 
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aggregation of tau proteins as helical filaments. Intracellularly, these filaments build up and 
form neurofibrillary tangles (NFT). Even though the amount of hyperphosphorylated tau 
correlates well with the severity of AD, it is not yet clear whether NFT formation contributes 
to disease progression or represents rather a neuroprotective mechanism (Wang et al. 2012). 
The second hallmark of AD is extracellular plaques, which comprise small peptides of about 
4 kDa in size with a varying length of 37 to 43 amino acids, β-amyloid (Aβ). Monomeric Aβ 
is generated from amyloid precursor protein (APP). APP is a transmembrane protein and 
contains cleavage sites for different enzymes including α-, β- and γ-secretase. In the anti-
amyloidogenic pathway (Figure 1.3, left panel), cleavage by α- and γ-secretase leads to the 
production of APPsα (incorporating the amino-terminal part), p3 (incorporating a large 
portion of the transmembrane domain) and AICD (APP intracellular domain, incorporating 
the carboxy-terminal part). The truncated Aβ peptide p3 is pathologically irrelevant. In 
contrast, the first cleavage of the amyloidogenic pathway (Figure 1.3, right panel) is executed 
by β-secretase and releases APPsβ (incorporating the amino-terminal part). The remaining 
βAPP carboxy-terminal fragment (CTF) is subsequently processed by γ-secretase, resulting in 
AICD and Aβ (Haass et al. 2012). 
Due to the presence of multiple cleavage sites for γ-secretase activity and a certain 
imprecision of the execution, there are several different species of Aβ. These differences are 
biologically relevant, because longer forms like Aβ42 are particularly prone to form highly 
toxic oligomers. Oligomers then assemble as (proto-)fibrils and later aggregate to amyloid 
plaques (Masters & Selkoe 2012) (Figure 1.4). 
Interestingly, certain mutations causing familial AD were found to enhance the 
amyloidogenic pathway and to alter APP in a way favoring the production of longer Aβ 
species. Likewise, people born with an additional copy of APP due to trisomy 21 show AD 
like symptoms early in life. This genetic evidence is the strongest support for the amyloid 
Figure 1.4: Aggregation of Aβ from 
monomers to plaques. 




cascade hypothesis presenting Aβ as the causative agent of AD (Hardy & Higgins 1992; 
Hardy & Selkoe 2002). 
1.4.2.1 Clearance of Aβ 
In general, abnormal accumulation of a substance is due to an imbalance of production and 
clearance. Interestingly, the level of APP in the cerebrospinal fluid of AD patients was 
reduced compared to non-demented controls (Van Nostrand et al. 1992; Mawuenyega et al. 
2010), suggesting that contrary to the animal models used for research, AD patients do not 
suffer from an overproduction of APP. Even though familial AD presents with more Aβ due 
to an enhanced amyloidogenic processing of APP, this is not the case in sporadic AD and 
thus, brings into focus the mechanisms by which Aβ is removed. 
In the CNS, a multi-layered cleaning system comprising general and specific mechanisms is 
responsible for the clearance of Aβ. General, unspecific elimination of waste including Aβ 
occurs via the glymphatic system, a general fluid stream guiding substances from the CNS 
parenchyma towards lymphatic vessels from where they are removed (Nedergaard 2013; 
Louveau et al. 2015). Specific elimination at the level of the BBB may be supported by ATP-
binding cassette (ABC) transporters, which can dispose Aβ into the periphery (Krohn et al. 
2011; Pahnke et al. 2014). 
In addition to its transport out of the CNS, the in situ proteolytic degradation is another way to 
specifically remove Aβ. There are multiple proteases breaking down Aβ, including the 
metalloproteases neprilysin (NEP), insulin degrading enzyme (IDE), and matrix-
metalloprotease 9 (MMP9) (Saido & Leissring 2012). NEP is one of the major regulators of 
Aβ and is almost exclusively expressed in neurons (Fukami et al. 2002). IDE is also of great 
importance for degradation of Aβ, and is expressed in a wide range of tissues (Yfanti et al. 
2008). MMP9 is of particular interest, because it is one of the few enzymes that can degrade 
monomeric as well as oligomeric/fibrillar Aβ (Yan et al. 2006). Despite Aβ being a substrate 
for many different peptidases and proteases, the lack of only one can have a significant impact 
on β-amyloidosis (Iwata et al. 2001; Yin et al. 2006). Accordingly, increased expression of 
IDE or NEP led to reduced levels of Aβ (Leissring et al. 2003). 
Notably, most of the proteases can be found in the extracellular space, as well as within the 
cells, for example in endosomes (Saido & Leissring 2012). This is important, because in 




1.4.3 Immune system & Alzheimer’s disease 
The role of immune cells, in particular innate immunity in the pathogenesis of AD is far from 
being fully understood, despite a high number of published studies. Even though immune 
cells may influence the course of disease on many layers, two prominent fields of action stand 
out: First, the secretion of mediators including cytokines and chemokines, and second, the 
clearance of Aβ. Together, local glia cells and infiltrating immune cells modulate disease 
progression by engaging in these tasks – or failing to do so. 
1.4.3.1 Microglia 
Driving force of the inflammation found in AD are the intrinsic immune cells of the CNS. 
Indeed, microglia are in intimate proximity to Aβ plaques (Itagaki et al. 1989) and express 
receptors for Aβ (including CD36 and SCARA-1), inducing activation and stimulating Aβ 
uptake (Yu & Ye 2015). It is of note that Aβ is continuously present in AD and thus, results in 
chronic activation and inflammation, which other than in acute injury like stroke cannot be 
resolved (Wang et al. 2014; Schwartz & Baruch 2014). 
Activation of microglia is characterized by morphological changes and secretion of cytokines 
including IL-6, TNF, and IL-1β (Prokop et al. 2013). There is evidence that the prolonged 
exposure to pro-inflammatory mediators can cause neuronal damage (Holmes et al. 2003; 
Holmes 2013). Subsequently, multiple studies have shown that long-term treatment with 
nonsteroidal anti-inflammatory drugs (NSAIDs) is inversely correlated with the risk for 
dementia in patients (reviewed in Heneka et al. 2015) and Aβ deposits in mouse models (Lim 
et al. 2000; Yan et al. 2003). However, the modulation of inflammation is not that simple. 
Many studies have shown that it strongly depends on which molecule is targeted when and 
results are not always conclusive (reviewed in Heppner et al. 2015). 
In addition to their role in (detrimental) inflammation, microglia also engage in beneficial 
processes in the course of the disease. As learned from acute axonal injury, microglia can 
protect neurons (Streit 2005), even though it is unclear whether they can utilize their full 
potential in AD. Microglia also possess the general tools for Aβ clearance, but they don’t 
seem to make a long-lasting contribution (Grathwohl et al. 2009). Moreover, microglia have 
been found to be functionally impaired in mouse models of AD compared to age-matched 
non-transgenic controls (Hickman et al. 2008; Krabbe et al. 2013). Accordingly, Schwartz and 
Baruch suggest that after microglia fail to fully restore tissue homeostasis (i. e. remove Aβ), 
their role as cytokine-producing cells overrides the benefits and leads to long lasting, 
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unresolved inflammation damaging the surrounding neuronal tissue (Schwartz & Baruch 
2014). 
Stimulation of microglia with harsh methods such as bacterial LPS could overcome the 
impairment and thus, was found to reduce β-amyloidosis when examined early after treatment 
(around one week in different studies). In the long run, however, the amount of plaques 
increased (reviewed in Prokop et al. 2013). 
1.4.3.2 Recruited monocytes 
One idea of dealing with the exhaustion of microglia is to replace or supplement microglia 
with fresh mononuclear cells from the periphery. While under healthy, physiological 
circumstances, they do not contribute significantly to the pool of microglia (Ajami et al. 2007; 
Ginhoux et al. 2010), monocytes/macrophages may represent potential effector cells to be 
recruited to the CNS. Their potential is underlined by the following four findings: 
First, their functional plasticity allows them to react differently to a wide range of stimuli 
(Gordon & Taylor 2005; Zigmond et al. 2012; Tacke & Zimmermann 2014). 
Second, similar to the CNS located microglia, monocytes can engage in phagocytosis and 
cytokine secretion (Biswas et al. 2015). 
Third, perivascular macrophages are monocyte progeny located in the perivascular space 
around the CNS vasculature. These macrophages are continuously replaced from the bone 
marrow and contribute to removal of amyloid deposited around blood vessels (Hawkes & 
McLaurin 2009). 
Fourth, in AD patients with comorbid stroke, macrophage recruitment to the CNS was 
observed and further, Aβ fibrils were detected within lysosomes of the macrophages, pointing 
out their capacity to take up Aβ (Wisniewski et al. 1991; Akiyama et al. 1996). 
Indeed, several studies have directly addressed the role of monocytes in mouse models of AD. 
It has been shown that the absence of monocytes in CCR2
-/-
 mice (where monocytes fail to 
exit from the bone marrow) worsens the early accumulation of Aβ and increases mortality (El 
Khoury et al. 2007). Accordingly, the enrichment of monocytes by peripheral injection of 
macrophage colony-stimulating factor (M-CSF) (Boissonneault et al. 2009), glatiramer 
acetate treatment or transplantation of CD115+ monocytes (Koronyo et al. 2015) reduced β-
amyloidosis. 
In contrast, in a comparative study of microglia, perivascular macrophages and parenchymal 
monocytes conducted by Mildner and colleagues, the beneficial effects were attributed to 
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perivascular and not to parenchymal macrophages/monocytes (Mildner et al. 2011). 
Interestingly, the authors also pointed out that CCR2 was necessary for Aβ clearance by 
perivascular macrophages, but not for their migration to the perivascular space (Mildner et al. 
2011).  
1.4.3.3 Age & infection 
Increased presence of immune cells including monocytes can be caused by infection. 
Interestingly, old age (the most important risk factor do develop AD) also comes with an 
increased susceptibility to infectious diseases. The prevalence of bacterial infections including 
pneumonia and urinary tract infections is increased by 3- to 20-fold amongst elderly 
individuals as compared to younger ones (Gavazzi & Krause 2002).  
Systemic inflammation can influence the milieu in the CNS via different routes, e. g. vagal-
nerve signaling and cytokine or cell signaling at the endothelium or choroid plexus (Perry et 
al. 2007). Systemic infection was further found to have a negative impact on cognitive 
functions in AD patients (Holmes et al. 2003). 
During life, people go through acute infections as well as acquire chronic infections. In line 
with this correlation, the seroprevalence of T. gondii infection increases with age (Jones et al. 
2001). Thus, the interesting question arises, how T. gondii influences the pathogenesis of AD. 
1.4.3.4 Toxoplasma gondii 
T. gondii is an obligate intracellular protozoan parasite which is able to infect all vertebrates. 
After oral ingestion of oocysts via contaminated food or water or tissue cysts via 
contaminated meat, the parasite causes a local acute infection of the small intestine (Dunay et 
al. 2008; Dunay et al. 2010). Only in the digestive tract of its definitive hosts from the feline 
family, T. gondii completes its life cycle and undergoes sexual replication to be shed as 
oocysts in the feces. In all other intermediate hosts, T. gondii spreads throughout the body via 
infected migratory cells including dendritic cells (John et al. 2011) and monocytes (Courret et 
al. 2006) and thus, establishes a systemic chronic infection. Long-term survival of the parasite 
is possible due to formation of cysts in non-replicating cells like muscle and neuronal cells 
(Munoz et al. 2011). 
As a wide-spread parasite with a strong tropism to the CNS, T. gondii has been suspected to 
contribute to the development of AD. However, results are not conclusive: A small study 
amongst AD patients confirmed T. gondii seropositivity as a possible risk factor for AD 
(Kusbeci et al. 2011), whereas Jung and colleagues suggested a beneficial effect of chronic 
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T. gondii infection in rodents (Jung et al. 2012). Moreover, a recent study did not find any 
differences with respect to seropositivity and –intensity between non-demented controls and 
AD patients (Perry et al. 2015).  
1.4.4 Mouse models for AD 
To better study the disease mechanism and possible treatment options, many mouse models 
have been developed mostly based on those gene mutations causing familial AD (Chin 2011). 
The models differ essentially with respect to the background mouse strain, the aspect of 
pathophysiology they mimic (amyloid plaques, neurofibrillary tangles, neurodegeneration, 
cognitive deficits), and the time the mice take to develop respective symptoms (Chin 2011). 
5xFAD mice with C57BL/6SJL background, which have been used for the present study, 
overexpress human APP (hAPP) under the neuronal murine Thy1 promotor. Five genetic 
mutations in the hAPP and the PSEN1 gene lead to a rapid and almost exclusive accumulation 
of Aβ42, visible plaque formation as early as 2 months after birth, neuronal loss at the age of 9 
months and measurable cognitive impairments starting at 4 to 6 months (Chin 2011; Fröhlich 




1.5 Aims of this thesis 
Part 1: Effect of monocytes on neurogenesis 
A growing number of studies indicate that the gut microbiome is able to influence immune 
homeostasis. Moreover, the immune system has been found to affect neurogenesis. 
Associating these findings with recent studies linking gut flora alterations to neuropsychiatric 
diseases, we aimed to investigate the following questions: 
I. How does manipulation of the gut flora affect neurogenesis levels in mice? 
In addition, if any change occurs, the subsequent aim was: 
II. How does the immune system signal from the gut to the CNS? 
 
Part 2: Role of monocytes in AD 
Given the robust recruitment of monocytes to the CNS upon chronic T. gondii infection in 
mice, we investigated the two following questions: 
III. How is T. gondii infection involved in the etiology of AD in mice? 




2 Materials and Methods 
2.1 Animal models 
The animals were handled according to governmental (LaGeSo) and internal (University of 
Magdeburg/MDC/Charité) rules and regulations. All mice were kept under a 12 hour 
light/dark cycle with 2-6 mice per cage and had access to food and water ad libitum. 
2.1.1 Wildtype mice (part 1) 
Female C57BL/6 wildtype mice for each individual experimental were randomly assigned to 
the different treatment groups and experiments were repeated independently two to three 
times. We need to emphasize, that not all treatment groups were included in each of the 




 mice and their heterozygote and wildtype littermates were housed and treated under 
SPF conditions in the animal facilities of the Cleveland Clinic, Cleveland Ohio, USA 
according to the governmental and federal law and recommendation. 
2.1.3 5xFAD 
Experiments were conducted with 8 weeks old C57BL/6J mice and female and male 5xFAD 
mice (5xFAD/Tg6799 strain (B6SJL-Tg(APPSwFlLon, PSEN1*M146L*L286V) 
6799Vas/Mmjax backcrossed for >10 generations to C57BL/6J, JAX stock#006554) (Oakley 
et al. 2006; Teipel et al. 2011). In this model, Aβ plaques in the brain are detectable from the 
age of 50 days and their number increases by age (Fröhlich et al. 2013). At least five animals 
per group in up to two independent experiments were used. 
2.1.4 T. gondii infection 
T. gondii cysts of the ME49 type II strain were used for this study. Parasites were harvested 
from the brains of female NMRI mice strain infected intraperitoneally (i. p.) with 10 T. gondii 
cysts 5 to 10 months earlier. Brains obtained from infected mice were mechanically 
homogenized in 1 mL sterile phosphate-buffered saline (PBS) and the cysts counted using a 
light microscope. If not stated otherwise, two cysts were administered i. p. into 8-week-old 
mice in a total volume of 200 µL. This time point was chosen because at the age of 8 weeks, 
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animals are fertile and are considered adults in this respect. At the chronic stage of infection 
(8 weeks post infection and 4 weeks post infection for depletion and phagocytosis assays, see 
below), mice were sampled. 
2.2 Experimental design & procedures 
2.2.1 Antibiotic and probiotic treatment 
Since commensals are required for normal development especially of the immune and 
nervous system, we used a model of antibiotic induced dysbiosis according to the protocol 
published previously (Heimesaat et al. 2006). The antibiotic compounds were applied via the 
drinking water for 7 weeks and consisted of ampicillin plus sulbactam (1.5 g/L; Pfizer), 
vancomycin (500 mg/L; Cell Pharm), 0.5 mg/L ciprofloxacin (200 mg/L; Bayer Vital), 
imipenem plus cilastatin (250 mg/L; MSD), and metronidazol (1 g/L; Fresenius). 72 h before 
gut flora reconstitution, the antibiotic treatment was discontinued and replaced by sterile tap 
water. Then antibiotic-treated mice were per orally challenged with a 300µL of fecal 
transplant by gavage on two consecutive days. The fecal transplant constituted of a mixture 
from 1 mg feces of 3 different naïve SPF mice dissolved in 15ml PBS. In parallel to the fecal 
transplants, the Abx plus probiotics group received VSL#3
®
 (Sigma-Tau Pharmaceuticals, 
Inc. Gaithersburg, MD) probiotics orally by gavage on two consecutive days. VLS#3 is a 
commercially available probiotic mixture consisting of 8 bacterial strains: Streptococcus 
thermophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, 
Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus 
delbrueckii subsp. Bulgaricus. We dissolved a total of 4.5x10
9
 probiotics into 10 mL PBS. By 
gavaging 300 µl, each mouse received approximately 1x107 probiotic bacteria. 
2.2.2 Voluntary exercise 
Mice with access to a running wheel were housed in pairs to avoid single housing, which can 
result in social deprivation that has an impact on neurogenesis per se. We glued a small 
magnet at the bottom rim of the wheels and monitored the rotations using a cycling computer 
during the active phase from 6pm – 8am. Knowing the diameter of the wheel (17cm) we were 
able to calculate the distance the two mice ran per active phase. We monitored the running 
groups over 10 days and calculated an average distance for each group. 
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2.2.3 Adoptive transfer 
Ly6C
hi
 monocytes were isolated from the bone marrow of C57BL/6 mice using FACS sorting 




 monocytes were injected into the tail vein of adult female 
C57BL/6 antibiotic-treated mice. The procedure was repeated 48 h later followed by BrdU 
injections. 
2.2.4 Monocyte depletion in non-infected wildtype mice 
Depletion of monocytes with 75 µg/injection anti-CCR2 monoclonal antibody (MC-21, 
kindly provided by M. Mack, University of Regensburg) and neutrophil granulocytes with 
440 µg/injection anti-Ly6G monoclonal antibody (1A8, BioXCell) was started on d0 by i. p. 
injection of the respective antibody in 300µL PBS. BrdU was injected on d1 - d3. Antibody 
injections were continued every third day until d20 and animals were sacrificed on d21. 
Control animals received 75 µg polyclonal rat IgG (BioXCell). 
2.2.5 Monocyte ablation in T. gondii infected 5xFAD mice 




 monocytes, 66 µg of anti-CCR2 antibody (clone MC-21, 
kindly provided by M. Mack, University of Regensburg) were administered i. p. on d15, d18, 
d21, d24 and d27 post infection. Control mice received PBS. On d22 (12-15h post antibody 
injection), blood was collected retro-orbitally to confirm depletion. Mice were sacrificed and 
samples were collected on d28. 
2.3 Organ collection 
For organ sampling, mice were deeply anesthetized and if necessary blood was drawn from 
the inferior vena cava using a 26 G needle and syringe. Subsequently, mice were perfused 
intracardially with 60 mL sterile ice-cold PBS. The required organs were removed and 
prepared accordingly for further analysis. 
2.4 Nucleic acid isolation 
After removal, tissue samples from brains were immediately transferred to RNA later 
(QIAgen, Germany). They were kept at 4 °C for at least 24 h and then stored at -20 °C until 
RNA isolation. For total RNA isolation, the tissue was removed from RNA later and 
homogenized with 1mL of TriFast (peqGOLD, Erlangen, Germany) in BashingBeads tubes 
(Zymo Research, Freiburg, Germany). PeqGOLD HP Total RNA Kit was used for 
purification and manufacturer’s instructions were followed. On-membrane DNase I digestion 
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(peqGOLD, Erlangen, Germany) was performed and RNA purity and concentration was 
determined by absorbance at 230, 260 and 280 nm in a NanoDrop (Fisher Scientific, 
Germany). 
2.5 Real Time Polymerase Chain Reaction (RT-PCR) 
2.5.1 RT-PCR from whole-brain homogenates 
Relative gene expression was determined similar to previous descriptions (Möhle et al. 2014; 




 1-Step Kit (life technologies, Germany). 
Reactions were developed in a LightCycler
®
 480 Instrument II (Roche, Germany). Reverse 
transcription was performed for 15min at 48°C followed by 10min at 95°C. Subsequently, 45 
amplification cycles were run, comprising of denaturation at 95°C for 15sec and 
annealing/elongation at 60°C for 1min. TaqMan
®
 Gene Expression Assays (life technologies, 
Germany) were used for mRNA amplification of APP (Hs00169098_m1), BDNF 
(Mm04230607_s1), HPRT (Mm01545399_m1), IDE (Mm00473077_m1), IFN-γ (IFNG, 
Mm00801778_m1), IL-1β (IL1B, Mm00434228_m1), IL-6 (IL6, Mm00446190_m1), IL-10 
(IL10, Mm00439616_m1), MMP9 (Mm00442991_m1), NEP (MME, Mm00485028_m1), 
NGF (Mm00443039_m1), TGF-β (TGFB1, Mm01178820_m1) and TNF 
(Mm00443258_m1). HPRT mRNA expression was chosen as reference for normalization and 
target/reference ratios were calculated with the LightCycler® 480 Software release 1.5.0 
(Roche, Germany). Resulting data were further normalized to values of appropriate control 
groups. 
2.5.2 RT-PCR from sorted cell populations 
Isolated brain single cell suspensions were surface stained as described below and sorted on a 
BD FACSAria
TM
 III. After sorting, cells were pelleted, any remaining liquid was removed 
and cells were frozen at -80°C. Total RNA was isolated using the RNeasy
®
 Mini Kit 
(QIAgen, Germany). cDNA was synthetized with the iScript™ cDNA Synthesis Kit (BIO-
RAD, Germany). Relative gene expression was measured using the TaqMan
®
 Universal PCR 
Master Mix (Applied Biosystems, Germany). TaqMan
®
 Gene Expression Assays (life 
technologies, Germany) and data analysis was the same as for RT-PCR from whole-brain 
homogenates. 
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2.6 Protein extraction 
For protein extraction, freshly harvested brain tissue was snap-frozen in liquid nitrogen and 
stored at -80 °C until further purification. 
2.6.1 Total β-amyloid 
For isolation of total β-amyloid42 (Aβ42), one hemisphere was homogenized in 1.5 mL 5 M 
guanidine hydrochloride (GuHCl) buffer (5M GuHCl in 50mM Tris/HCl, pH 8.0) using an 
Ultra-Turrax
®
 T8 (IKA, Germany). Afterwards, homogenates were shaken at 150 U/min for 
4 h at room temperature (RT) and then stored at -20 °C for analysis. Prior to ELISA analysis, 




) containing 5 % bovine serum albumin, 
0.03 % Tween-20 and protease inhibitor (Roche, Germany) and centrifuged at 16000 rpm for 
20 min. The supernatant was further used as described in chapter 2.7. 
2.6.2 Carbonate buffer and guanidine soluble Aβ 
To discriminate between small (carbonate buffer soluble) and large (guanidine soluble) Aβ42 
aggregates, 20mg brain homogenate were homogenized in 400 µl carbonate buffer (100 mM 
Na2CO3 in 50 mM NaCl, pH 11.5) including protease inhibitor (Roche, Germany) and 
centrifuged at 14000 rpm for 20 min. The supernatant was adjusted with 8.2 M GuHCl in 
82 mM Tris/HCl (0.6ml GuHCl/1ml carbonate buffer), again centrifuged at 14000 rpm for 
20 min and stored at -20 °C until further analysis. The pellet from the first centrifugation step 
was dissolved in 160 µL 5 M GuHCl in 50 mM Tris/HCl, shaken at 1500 rpm for 3 h at RT 
and also centrifuged at 14000 rpm for 20 min. The supernatant was stored at -20 °C until 
further analysis as described in chapter 2.7. 
2.7 ELISA 
Aβ42 was quantified in whole brain hemispheres by ELISA against human Aβ42 (Thermo 
Fisher Scientific, Germany). Prior to ELISA analysis, each extract (total, soluble and 
insoluble) was diluted with BSAT-PBS (5% bovine serum albumin in PBS with 0.03% 
Tween-20 and protease inhibitor (Roche, Germany)) according to the expected Aβ42 content. 
ELISA was then performed according to the manufacturer’s instructions. 




2.8.1 Analysis of BrdU-labeling and co-labeling 
2.8.1.1 BrdU treatment 
For the analysis of cell proliferation and survival, the animals received i. p. injections of 50 µg 
BrdU (Sigma-Aldrich)/g body weight at a concentration of 10 mg/mL BrdU in sterile 0.9 % 
NaCl solution for three consecutive days and were examined four weeks later (if not stated 
otherwise). Please note that the BrdU injections for our experiments were performed in 
different labs (University of Magdeburg, Charité Berlin or Cleveland Clinic, Ohio). Despite 
keeping protocols and substances similar across labs, individual injection techniques and 
volumes account for differences in baseline BrdU cell numbers. Thus, we always included a 
matching control group in each individual experiment and one should not compare baseline 
BrdU numbers across experiments. 
2.8.1.2 Immunolabeling 
Brains were cryopreserved in 30 % sucrose overnight, rapidly frozen in dry ice and mounted 
onto a sliding microtome. 40 µm thick sections were collected into cryoprotecting buffer 
(25 % glycerol, 25 % ethylenglycol in 0.05 M PBS). Before immunolabeling, sections were 
washed with PBS and blocked by incubation on a shaker in 0.6 % H2O2 (in PBS) for 30 min 
at RT. For BrdU labeling, sections were treated with 2 N HCl for 30 min at 37 °C and with 
0.1 M borate buffer for 10 min at RT. The sections were again washed and incubated in 
blocking buffer (3 % donkey serum, 0.1 % TritonX100) for 1 h for permeabilization. The 
sections were then incubated overnight at 4 °C with the primary antibody (rat BrdU, 1:500, 
Biozol, Germany; goat Dcx, 1:200, Santa Cruz Biotechnology; mouse NeuN, 1:100, 
Millipore). Sections were washed and blocked for 30 min. For 3,3'-Diaminobenzidine (DAB)-
staining, the slices were incubated for 2 h in the secondary antibody (anti rat Biotin-SP-
conjugated, Dianova, at RT). After washing, the third antibody was incubated for 1 h (HRP-
conjugated streptavidin, Dianova, at RT), following detection via DAB. The reaction was 
stopped with water. For immunofluorescence labeling, the slices were labeled by incubation 
with a fluorophore-labeled antibody (anti goat Alexa488, anti-mouse Cy5, and anti-rat Cy3, 
all 1:250, Dianova). 
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2.8.1.3 Confocal microscopy 
For confocal microscopy we used a Leica SPE microscope (Leica microsystems, Germany) 
with appropriate gain and black level settings (determined on control tissues stained with 
secondary antibodies alone). Images were recorded as z-stacks and analyzed using Volocity 
LE software (PerkinElmer). 
2.8.1.4 Cell counting and unbiased stereology 
Cell counts were determined in an unbiased approach using the optical fractionator procedure 
of the StereoInvestigator software (MBF Bioscience, USA) for every 6th brain section 
containing the hippocampus. The obtained cell number was multiplied by the number of slices 
analyzed, to calculate the number of BrdU
+
 cells in the whole hippocampus. Since both 
hippocampi were counted, we used the total number of BrdU
+
 cells per brain as a unit. 
2.8.2 Immunohistological analysis 
Brain hemispheres were removed and immersed in 4% paraformaldehyde (PFA) for several 
days. Paraffin-embedded, 4 µm thick sections were deparaffinized and conventionally stained 
with hematoxylin-eosin (H&E) stain. Immunohistochemical analysis was performed 
according to our previous publications (Fröhlich et al. 2013; Hofrichter et al. 2013; Pahnke et 
al. 2013; Schumacher et al. 2012; Scheffler et al. 2012; Schmidt & Pahnke 2012; Krohn et al. 
2011) using a BOND-MAX (Leica Microsystems GmbH/Menarini, Germany) with antibodies 
against Aβ (clone 4G8, Chemicon, Germany), ionized calcium-binding adapter molecule 1 
(IBA1, Wako 019-19741, Germany) to label microglia, glial fibrillary acid protein (GFAP, 
DAKO Z033401, Germany) to label astrocytes, NeuN (Millipore MAB377, Germany) to 
label neurons, and anti-Toxo (Dianova DLN-16734, Germany) to label T. gondii. Slides were 
developed using the Bond
TM
 Polymer Refine Detection kit (Menarini/Leica, Germany). For 
the evaluation whole tissue sections were digitized at 230 nm resolution using a MiraxMidi 
Slide Scanner (ZeissMicroImaging GmbH, Germany) (Scheffler et al. 2011). 
2.8.3 Immunofluorescence analysis 
For immunofluorescent staining, coronal brain sections (16µm) were prepared with a 
cryomicrotome (Leica, Germany). Immunolabeling with antibodies against Aβ (4G8, 
Chemicon, Germany), Iba1 (polyclonal, Wako) and Ly6C (ER-MP20, Acris Antibodies, 
Germany) were performed overnight at 4°C after 2 min pretreatment with 98% formic acid. 
Secondary antibodies goat anti-rat (Alexa Fluor 488, 1:200, Invitrogen, Germany), goat anti-
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rabbit (Alexa Fluor 488, Invitrogen, Germany) and goat anti-mouse (Alexa Fluor 594, 
Invitrogen, Germany) were used. Free floating sections were mounted with ProLong Gold 
with DAPI (life technologies, Germany). A Zeiss (Carl Zeiss, Germany) microscope equipped 
with an AxioCam HRc 3 digital camera and AxioVision 4 Software were used to analyze 
staining and obtain images. 
Quantification of Iba1 and Ly6C association with plaques was performed using the ImageJ 
plot profile function (http://imagej.nih.gov/ij/). For this purpose, two perpendicular 
fluorescence profiles spanning 400 µm and centered over the plaques were measured in 
immunofluorescence stainings. At least 30 plaques from at least four different tissue sections 
were analyzed. 
2.8.4 Two-Photon image acquisition and analysis 
For in vivo staining of amyloid plaques, mice were i. p. injected with 10mg kg-1 methoxy-X04 
(Tocris Bioscience) in 5% DMSO/95% NaCl (0.9%) 12 hours before brain harvesting and 
two-photon image acquisition. 
Brains were placed under microscopy coverslips for ex vivo microscopy using a Zeiss LSM 
710 (Carl Zeiss, Jena, Germany) equipped with a MaiTai DeepSee 2-Photon laser (Spectra-
Physics, Darmstadt, Germany) tuned at 800nm. Fluorescence emission was split using a 
dichroic mirrors and detected using non-descanned detectors. Methoxy-X04 fluorescence was 
read out at 450-490nm. Fluorescence signal acquired above 520nm was considered 
autofluorescence. Confocal stacks spanning at least 50µm were collected with a z-spacing of 
4µm using a W Plan-Apochromat 20x water immersion objective with a numerical aperture of 
1.0. 
Images were processed and superimposed using the Imaris (Version 7.7., Bitplane, Zürich, 
Switzerland) software. Methoxy-X04-positive objects co-localizing with blood vessels 
(identified by different tissue autofluorescence) were manually excluded from the analysis. 
Plaques were automatically detected and quantified in three dimensions using the 
measurement package of the Imaris software. 
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2.9 Primary cell isolation 
2.9.1 Brain 
For mononuclear cell isolation brains were homogenized in a buffer containing 1 M Hepes 
pH 7.3 and 45 % Glucose and then sieved through a 70 µm strainer as published previously 
(Möhle et al. 2014). The cell suspension was washed and re-suspended in 10 mL 75 % Percoll 
(GE Healthcare, Germany) in PBS and over layered with 10 mL 25 % Percoll in PBS and 
5 mL PBS. The gradient was centrifuged for 45 min at 800 g without brake. Cells were 
recovered from the 25 %/75 % interphase, washed and used immediately for further 
experiments. 
2.9.2 Blood, bone marrow 
Blood from the inferior vena cava was diluted in FACS buffer. To obtain the bone marrow, 
femur and tibia were isolated and surrounding tissue was removed. The proximal and distal 
ends were removed and a syringe with a 26 G needle attached was inserted to wash out bone 
marrow cells with FACS buffer. 
The cell suspensions were spun down (400 g, 10 min, 4°C) and after carefully discarding the 
supernatant, lysis of erythrocytes was performed in 1 mL RBC lysis buffer (eBioscience, 
Germany) for 8 min on ice. After washing with PBS, cells were ready for further analysis. 
2.10 Flow cytometry 
2.10.1 Surface staining 
Single cell suspensions were incubated with an anti-FcγIII/II receptor antibody (clone 93) to 
block unspecific binding and Zombie Violet
TM
 (Biolegend, Germany), a fixable viability dye. 
Thereafter, cells were stained with fluorochrome conjugated antibodies against cell surface 
markers: CD45 (1:200, 30-F11, eBioscience, Germany), CD11b (1:333, M1/70, eBioscience, 
Germany), Ly6G (1:100, 1A8, BD Biosciences, Germany), Ly6C (1:333, HK1.4, 
eBioscience, Germany), MHC I (1:200, 28-14-8, eBioscience, Germany), MHC II (1:200, 
M5/114.15.2, eBioscience, Germany), CD11c (1:333, N418, eBioscience, Germany), F4/80 
(1:100, BM8, eBioscience, Germany), CCR2 (1:33, 475301, R&D, USA), TREM2 (1:33, 
237920, R&D, USA), CD36 (1:100, HM36, Biolegend, Germany), in FACS buffer (PBS 
containing 2% FCS and 0.1% NaN3) for 30min on ice and then washed and fixed in 4% 
paraformaldehyde (PFA) for 10min. 
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2.10.2 Conventional flow cytometry 
Cell acquisition was performed on BD FACS Canto
TM
 II flow cytometer. Data were analyzed 
using FlowJo software (TreeStar). 
2.10.3 Imaging flow cytometry 
Data were acquired with FlowSight
TM
 (EMD Millipore, USA) with a 20x objective and 
analyzed using IDEAS software version 6.0. At least 52,000 (control animals) or 500,000 
(T. gondii infected animals) cells were acquired for each sample and gated to select images 
with single cells in good focus (by bright field area/aspect ratio and gradient root mean square 
of the bright-field image, respectively). To analyze internalization, the erode mask was used 
on the bright field picture of Aβ+ cells to remove 2 pixels from the edges of the starting mask 
and to define the inner part of the cell. Then, the internalization feature was used to define the 
ratio of intensity of the Aβ signal between the inside of the cells (defined by the erode mask) 
and the intensity of the total cell. While cells with little internalization have negative scores, 
cells with high internalization have positive scores. Here, an internalization>0 was defined as 
intermediate to high internalization. Compensation matrix generated by single-color 
compensation controls was used to correct spectral overlap. Representative pictures from cell 
populations were chosen. 
2.11 Ex vivo phagocytosis assay 
Animals were sacrificed 4 weeks post infection and single cell suspensions were prepared as 
described above. Live cells remained unstained by the Zombie Violet
TM
 (Biolegend, 
Germany) viability dye and were sorted on a BD FACSAria
TM
 III. 150,000 cells were seeded 
into each well of a 96-well round bottom plate and allowed to settle down for 1 hour in an 
incubator (37°C, with 5% CO2 and 70% humidity) before HiLyte Fluor
TM
 488-labeled, HFIP 
monomerized Aβ42 (Eurogentec, Belgium) was added to a final concentration of 500nM. Cells 
were incubated for 6 hours, washed, surface stained and measured by conventional and 
imaging flow cytometry. 
2.12 Statistical analysis 
Statistical analysis was performed with Prism version 6 (GraphPad Software, USA). p values 
of p≤0.05 were considered statistically significant. 
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2.12.1 Statistical analysis of results for part 1 (Neurogenesis) 
Before we started statistical analysis, we tested for normality with a normality probability 
plot. For parametric data we used for all neurogenesis analysis: two-way ANOVA, with 
Bonferroni post hoc and for the FACS analysis either one-way ANOVA followed by a 
Fisher’s LSD test or unpaired two-tailed Student’s t test. When we tested with the F test, 
similar variances were detected in the groups included in the test. Significances are depicted 
in the respective figure legends as mean + standard error of the mean (SEM). We performed 
Dixons Test for single outlier, but did not detected outliers in our data set. When we sacrificed 
the animals, we prepared a list with animal IDs. We prepared the specimens for further 
analysis and coded the samples in order to do a blind analysis afterwards. The investigator 
who analyzed the samples was blind to the animal’s treatment group. 
2.12.2 Statistical analysis of results for part 2 (Alzheimer’s disease) 
Results are presented as mean + SEM. Different tests were used to compare values, namely 
Mann-Whitney U test (plaque numbers and volume), Fisher’s LSD test (results with multiple 
comparisons) and unpaired two-tailed Student’s t test (results with one comparison). p values 
of p≤0.05 were considered statistically significant. 
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3 Results 
3.1 Role of monocytes in neurogenesis 
The work presented in the first part of the results has been performed in collaboration with the 
research group of Dr. Susanne Wolf (MDC Berlin), where neurogenesis levels were 
determined by BrdU immunolabeling and analyses. 
3.1.1 Antibiotic treatment decreases adult hippocampal neurogenesis 
Adult C57BL/6 mice were treated with broad-spectrum antibiotics (Abx) for seven weeks, 
which has been shown previously to eliminate the intestinal microbiota (Heimesaat et al. 
2006). In these antibiotic-treated mice, we labeled proliferating cells by injection of BrdU, a 
thymidine analog that is incorporated into the DNA during cell replication. Analysis of the 
hippocampi was performed four weeks after BrdU injections (Kempermann & Gage 2000), to 
analyze the survival of generated neurons (i. e. net neurogenesis). Proliferated cells were 
further characterized based on their expression of the phenotypical markers Dcx and NeuN. 
Dcx labels the majority of proliferating mitotic neuronal progenitor cells and marks the time 
point of commitment to the neuronal lineage, while NeuN is expressed by mature neurons. In 
this thesis, I will present the basic quantification of BrdU
+
 cells, the full phenotyping will be 
available in the publication. 
In immunofluorescence labeled brain sections including the hippocampus we detected that the 
number of BrdU
+
 cells in the SGZ of the DG was significantly lower in the brains of 
antibiotic-treated (Figure 3.1A and B, light blue bars) compared to naïve SPF mice (Figure 
3.1A and B, light grey bars). These first data suggest that antibiotic treatment has a long 




Figure 3.1: Reduced neurogenesis in antibiotic-treated mice can be partially restored by running. 
(A) The total number of BrdU
+
 cells was quantified from naïve SPF mice or SPF mice treated with antibiotics (Abx 
treated). One group of mice received a fecal transplant (Abx + SPF transplant), and half the mice in each group 
were given access to a running wheel (darker bars, running +). Two-way ANOVA with Bonferroni post hoc test. 
***p<0.001. 
(B) The total number of BrdU
+
 cells normalized after probiotic treatment. Two-way ANOVA with Bonferroni post 
hoc test. ***p<0.001. 
 
3.1.2 Running rescues neurogenesis levels despite antibiosis 
Many factors have been shown to influence neurogenesis, such as sex, drugs, stress, diet and 
physical activity (reviewed in Ming & Song 2005). Amongst these, we were particularly 
interested in the effect of physical activity, because exercise is easily available for patients, 
e. g. antibiotic-treated individuals. To test if physical exercise affects neurogenesis, especially 
in antibiotic-treated mice, we supplied mice with running wheels for ten days during the 
treatment, injected BrdU for the last three days of exercise and assessed neurogenesis four 
weeks later. Exercise duration was similar across all groups, covering a distance of 
0.28±0.05 km/day. Access to running wheels significantly increased neurogenesis by 44 % in 
naïve SPF mice (Figure 3.1A, dark grey bar). In antibiotic-treated mice, the beneficial effect 
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of exercise was less pronounced and neurogenesis was only increased by 28 % (Figure 3.1A, 
dark blue bar). After reconstitution of the intestinal flora with a fecal transplant, exercise 
increased neurogenesis levels again by 47 % (Figure 3.1A, dark brown bar) similar to its 
effect on naïve SPF mice. 
3.1.3 Probiotics fully restore neurogenesis 
After observing the significant reduction of neurogenesis accompanying gut microbiota 
depletion, we were interested if reconstitution with a complex gut flora rescues neurogenesis. 
To this end, mice received a fecal transplant from naïve SPF mice two days after 
discontinuation of the antibiotic treatment. After allowing the flora to settle for seven days, 
we injected BrdU and analyzed neurogenesis levels four weeks later. Even though the 
intestinal flora was restored in mice by the SPF transplant (data not included in this thesis), 
this recovery had little effect on the hippocampal neurogenesis (Figure 3.1A and B, light 
brown bars). Another group of antibiotic-treated mice received VSL#3 probiotics instead of 
an SPF transplant. In these probiotic-treated mice, the number of proliferated cells was back 
to naïve SPF levels (Figure 3.1B, dark red bar). Control treatment of naïve SPF mice with 
probiotics did not increase neurogenesis (Figure 3.1B, light red bar). These results indicate 
that the impairment of neurogenesis by antibiotic treatment can only be restored by treatment 
with probiotics and not with conventional SPF flora. 
3.1.4 Expression of soluble mediators in the brain remains unaltered upon changes of 
the intestinal flora 
Soluble mediators contribute to brain homeostasis including neurogenesis. Among others, 
TNF (Iosif et al. 2006) and BDNF (Scharfman et al. 2005; Rossi et al. 2006) were reported to 
directly influence neurogenesis. 
TNF mRNA expression as measured by RT-PCR was the same in whole-brain and 
hippocampus extracts and remained unchanged upon treatment with antibiotics (Figure 3.2A; 
brain: naïve SPF 1.0±0.1, Abx treated 0.9±0.05; hippocampus: naïve SPF 1.6±0.05, Abx 
treated 1.5±0.1). While BDNF mRNA expression was significantly higher in the hippocampus 
than in the rest of the brain, antibiotic treatment did not influence its expression in the whole 
brain or in the hippocampus alone (Figure 3.2B; brain: naïve SPF 1.0±0.2, Abx treated 




Figure 3.2: Expression of TNF and BDNF in whole-brain and hippocampus 
Four weeks after antibiotic treatment, total RNA was isolated from either one whole hemisphere (brain) or from 
the hippocampus only (hc). Relative expression of TNF and BDNF mRNA was measured by RT-PCR. Data are 
normalized on the naïve SPF group (brain) and presented as mean + SEM. Statistical analysis was performed 
using Fisher’s LSD test. ***p<0.001, ****p<0.0001. 
 
Extending the investigation of soluble factors, we measured the expression of TNF, IL-6, 
BDNF and NGF mRNA at two time points after reconstitution of the intestinal flora. Since we 
had not seen differences restricted to the hippocampus in our previous analysis, we conducted 
the experiment with whole-hemisphere extracts. 
We did not detect differences regarding the expression of the immune mediators TNF and IL-
6 both one and four weeks after reconstitution in any of the treatment groups (Figure 3.3A and 
B; TNF one week – SPF naïve 1.0±0.2, Abx treated 0.7±0.05, Abx + SPF transplant 0.8±0.1, 
probiotics 0.8±0.2; TNF four weeks – SPF naïve 1.0±0.1, Abx treated 1.0±0.2, Abx + SPF 
transplant 0.8±0.1, probiotics 0.9±0.1; IL-6 one week – SPF naïve 1.0±0.1, Abx treated 
0.9±0.05, Abx + SPF transplant 0.9±0.03, probiotics 0.9±0.06; IL-6 four weeks – SPF naïve 
1.0±0.1, Abx treated 1.1±0.3, Abx + SPF transplant 0.8±0.1, probiotics 1.1±0.03). Similar 
results were obtained for the expression of BDNF and NGF (Figure 3.3A and B; BDNF one 
week – SPF naïve 1.0±0.04, Abx treated 1.1±0.05, Abx + SPF transplant 1.2±0.09, probiotics 
0.8±0.06; BDNF four weeks – SPF naïve 1.0±0.08, Abx treated 1.0±0.09, Abx + SPF 
transplant 1.1±0.07, probiotics 1.1±0.1; NGF one week – SPF naïve 1.0±0.04, Abx treated 
0.9±0.02, Abx + SPF transplant 0.9±0.04, probiotics 0.9±0.06; NGF four weeks – SPF naïve 
1.0±0.02, Abx treated 1.0±0.03, Abx + SPF transplant 1.0±0.02, probiotics 1.0±0.02). Even 
though BDNF expression was significantly reduced in mice receiving probiotic treatment 
(compared to the Abx treated and Abx + SPF transplant groups) at one week after 
reconstitution, this returned to normal after four weeks of antibiotic-free time. Reduced 
BDNF expression would point towards lower neurogenesis levels, whereas we had observed 




Figure 3.3: Expression of inflammatory and neurotrophic mediators in the brain 
(A) One or (B) four weeks after reconstitution with an SPF transplant or probiotics, total RNA was isolated from 
whole-hemisphere homogenates. Relative expression of TNF, IL-6, BDNF and NGF mRNA was measured by RT-
PCR. Data are normalized on the naïve SPF group and presented as mean + SEM. Statistical analysis was 
performed using Fisher’s LSD test. *p>0.05, **p<0.01. 
 
Taken together, none of the quantified soluble mediators explained the previously described 
changes in neurogenesis, as they all remained largely unaltered upon treatment with anti- or 
probiotics. 
3.1.5 Ly6Chi monocytes provide a link between brain, gut and treatment paradigms 
The neuronal associations between the gut and the brain are well known (Mayer 2011) and 
recent evidence suggests that both structures may be further linked by the immune system. 
Previous studies indicate that immune cells help to maintain neurogenesis levels (Wolf et al. 
2009; Ziv et al. 2006). Interestingly, immune cells can be influenced by antibiotics (Morgun 
et al. 2015) as well as exercise (Shantsila et al. 2012). Therefore, we explored if mononuclear 
innate immune cells in the brain may act as a link between brain, gut and exercise. 
We analyzed the immune cell subpopulations infiltrating the brain by flow cytometry. 
Mononuclear cells isolated from whole-hemisphere homogenates were stained for CD45, 
CD11b, Ly6G and Ly6C. Figure 3.4A illustrates the gating strategy for Ly6C
hi
 monocytes in 
the brain: CD45
int CD11b+ microglia were discriminated from CD45hi CD11b+ infiltrating 
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myeloid cells. Within the myeloid population we further separated Ly6G
+




We detected that the percentage of Ly6C
hi
 monocytes had dropped almost by half in 
antibiotic-treated mice compared to naïve SPF mice (Figure 3.4C, light grey and light blue 
bars; naïve SPF: 0.26±0.1%; Abx: 0.16±0.05 %). This decrease was also evident in bone 
marrow and blood, even one week after discontinuation of antibiotic treatment and 
transplantation of SPF flora (Figure 3.5B and E). Four weeks after transplantation of SPF 
flora, the number of Ly6C
hi
 monocytes was back to the naïve SPF level in bone marrow and 
blood (Figure 3.5C and F). 
Reconstitution of the intestinal flora with an SPF transplant did not rescue the Ly6C
hi
 
monocyte population in the brain (Figure 3.4C, light brown bar; 0.14±0.02 %). Reconstitution 
with probiotics on the other hand significantly increased the number of Ly6C
hi
 monocytes in 
the brain (Figure 3.4C, dark red bar; 0.46±0.15 %). Similarly, exercise in the form of access to 
a running wheel increased the number of Ly6C
hi
 monocytes in the brain of antibiotic-treated 
mice (Figure 3.4C, dark blue bar; 0.27±0.06 %). Of note, only exercise and not probiotic 
treatment could raise Ly6C
hi
 monocyte numbers in naïve SPF mice. 









 populations (Figure 
3.4B). The number of intrinsic microglia remained unaltered upon all experimental groups 
(Figure 3.4D). 
Interestingly, the measured alterations in the Ly6C
hi
 monocyte population matched the pattern 
we had previously observed for hippocampal neurogenesis levels. We found reduced Ly6C
hi
 
monocyte numbers as well as decreased neurogenesis levels in antibiotic-treated compared to 
naïve SPF mice. Correspondingly, the neurogenesis rescue by running or probiotic treatment 
(Figure 3.1) was paralleled by an increase in the Ly6C
hi





Figure 3.4: The number of Ly6C
hi
 monocytes is reduced in the brain of antibiotic-treated mice and is 
rescued by exercise but not by fecal transplant. 
(A) Cells isolated from brains were stained for CD45, CD11b, Ly6G and Ly6C for flow cytometric analysis. 








myeloid cells (upper right quadrant). The right-hand 
plot displays how we separated Ly6G
+
 neutrophils from Ly6C
hi
 monocytes within the myeloid population. 
(B-D) Bar graphs display the number of (B) total myeloid cells, (C) Ly6C
hi
 monocytes, and (D) microglia in brain 
homogenates as percentage of CD11b
+
 cells. Fisher’s LSD test. *p<0.05, **p<0.01, ***p<0.001. 
(E) To visualize the location of the Ly6C
hi
 monocytes, we utilized a reporter for CCR2 (RFP) and CX3CR1 
(EGFP). (E’) Localization of the choroid plexus within the 3
rd
 ventricle, cell nuclei stained with DAPI (white), 10x 
objective. (E’’) Representative images of CCR2
+
 cells (blue) in the choroid plexus (DAPI white) that are distinct 
from CX3CR1 expressing cells (green), 20x objective. (E’’’) Representative picture of a CCR2
+
 cell (blue) in the 
hippocampus (DAPI white, CX3CR1 green), 20x objective. In the insert within the CCR2 single channel image we 
zoomed on the single CCR2 expressing cell with a 63x objective (merge of DAPI in white, CCR2 in blue and 





Figure 3.5: Kinetics of the Ly6C
hi
 monocyte populations in bone marrow and blood during gut 
reconstitution with SPF flora 
 (A, D) Cells isolated from peripheral organs were stained against specific surface markers for flow cytometric 
analysis. Representative pseudocolor plots demonstrate the gating strategies used to identify Ly6C
hi 
monocytes 









 population. The Ly6C
hi




(B) In the bone marrow, we found a lower proportion of Ly6C
hi
 monocytes in Abx treated animals reconstituted 
with SPF flora compared to SPF naïve one week after discontinuation of Abx treatment. 
(C) Four weeks after discontinuation of the Abx treatment and start of SPF fecal transplant, no differences in the 
proportion of Ly6C
hi
 monocytes in the bone marrow were measured between the groups. 
(E) In the blood, there were fewer Ly6C
hi 
monocytes in Abx treated than in SPF naïve mice one week after 
discontinuation. 
(F) Four weeks after discontinuation of the Abx treatment and start of SPF fecal transplant, the differences were 
no longer present and the same proportion of Ly6C
hi
 monocytes was found in all experimental groups. 
Unpaired two-tailed Student’s t test. *p<0.05, **p<0.01. 
 
Because the total number of Ly6C
hi
 monocytes is very low in the non-inflamed, non-infected 
brain parenchyma, the previous analyses were performed with single cell solutions prepared 
from whole-hemisphere homogenates. In addition to the quantitative approach, we were 
interested in the location of Ly6C
hi
 monocytes in the brain. Therefore, we used CCR2-RFP 
CX3CR1-eGFP reporter mice to visualize Ly6C
hi
 monocytes and resident microglia. CCR2 
has a substantial overlap with the Ly6C
hi
 population and labels infiltrating monocytes, while 
in the brain, CX3CR1 is expressed exclusively by (brain-)resident microglia. We detected the 
majority of CCR2
+
 cells in the choroid plexus (Figure 3.4E’), which has previously been 
described as an entrance gate for immune cells to the brain (Schwartz & Baruch 2014). Figure 
3.4E” shows representative images of CCR2+ cells (blue) in the choroid plexus (DAPI-labeled 
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nuclei in white) that are distinct from CX3CR1 expressing cells (green). While CCR2
+ Ly6Chi 
monocytes are abundant in the brain parenchyma of infected mice (Möhle et al. 2014), we 
rarely detected them here in non-infected brains. Figure 3.4”’ shows the hippocampus with a 
representative CCR2
+
 cell (CCR2 blue, DAPI white, CX3CR1 green). 
3.1.6 Lack of monocytes decreases neurogenesis 
To determine whether altered Ly6C
hi
 monocyte numbers were cause, effect or simply 
coincided with the rate of hippocampal neurogenesis, we used three different strategies to 
alter monocyte numbers: genetic depletion, antibody-induced depletion and adoptive transfer. 
 
Figure 3.6: Distribution of the Ly6C
hi
 monocyte population in CCR2
-/- 
mice. 
(A, C) Cells isolated from bone marrow and blood were stained against specific surface markers for flow 
cytometric analysis. Representative pseudocolor plots demonstrate the gating strategies used to identify Ly6C
hi 
monocytes from (A) bone marrow and (C) blood of wildtype (middle plots) and CCR2
-/- 





 cells were gated (left plots), amongst which the Ly6C
hi
 monocytes were then identified (middle and 
right plots). 
(B, D) The number of Ly6Chi monocytes in all three tissues was quantified as percentage of CD11b+ cells and is 
displayed as mean + SEM. n=2, unpaired two-tailed Student’s t test. ns, not significant, **p<0.01. 










Genetic depletion was achieved by knocking out CCR2. Lack of this chemokine receptor 
prevents CCR2
+ Ly6Chi monocytes from exiting the bone marrow and consequently reduces 
their number in the periphery (Serbina & Pamer 2006). We confirmed the general presence of 
Ly6C
hi
 monocytes in the bone marrow and their significantly decreased number in the 
periphery (Figure 3.6A-D). 
We found significantly less Ly6C
hi
 monocytes in the brains of CCR2
-/-
 compared to wildtype 
mice (Figure 3.6E and Figure 3.7B). Likewise, CCR2
-/-
 mice exhibited significantly decreased 
levels of adult hippocampal neurogenesis (Figure 3.7A). A direct effect of CCR2 on 
neurogenesis is unlikely, because neurogenesis remained unaltered in heterozygous CCR2
+/-
 
mice (Figure 3.7A). 
Since it is unclear how the continuous absence of CCR2 may affect the development of brain 
and immune system, we utilized a second model in which we targeted Ly6C
hi
 monocytes in 
adult mice. Injection of an anti-CCR2 monoclonal antibody (MC-21) specifically reduced the 
number of Ly6C
hi
 monocytes in the brain (Figure 3.7B). In contrast to macrophages, 
monocytes have a relatively short life span of maximum three to five days in the blood 
(Whitelaw 1966; Yona et al. 2013). One day after the first antibody treatment, we injected 
BrdU and evaluated the effect of the depletion on neurogenesis levels three weeks later. Here 
we found that the treatment of naïve SPF mice with MC-21 led to a 25 % decrease in total 
BrdU
+
 cells compared to IgG-treated controls (Figure 3.7A). The depletion of another subset 
of myeloid cells, namely Ly6G
+
 neutrophils (Figure 3.7E), did not have any effect on 
neurogenesis levels and Ly6C
hi
 monocyte numbers. Despite some alterations we have seen in 
the total myeloid population (Figure 3.4B), we can exclude a contribution of Ly6G
+
 
neutrophils in this case. 
Together, these two depletion studies suggest that CCR2
+ Ly6Chi monocytes are necessary to 








 monocytes results in decreased 
neurogenesis. 




 and wildtype littermates were analyzed four weeks after BrdU injections. 
(A) Neurogenesis was evaluated by counting BrdU
+
 cells in the hippocampus. Two-way ANOVA, Bonferroni post 
hoc test. ***p<0.001. 
(B) The decrease of Ly6C
hi
 cells as a proportion of CD11b
+
 cells in the brains of CCR2
-/-
 animals compared to 
wildtype littermates was measured using a gating strategy as in Figure 3.6E. Unpaired two-tailed Student’s t test. 
**p<0.01. 




 monocytes or 
an anti-Ly6G antibody (1A8) to deplete Ly6G
+
 neutrophils. 
(C) Neurogenesis was evaluated after three weeks of depletion by counting BrdU
+
 cells in the hippocampus. 
Unpaired two-tailed Student’s t test. ***p<0.001. 
(D, E) The proportion of (D) Ly6C
hi
 monocytes and (E) Ly6G
+
 neutrophils in the brain was measured as a 
percentage of CD11b
+




3.1.7 Neurogenesis can be rescued by adoptive transfer of Ly6Chi monocytes to 
antibiotic-treated mice 
To resolve whether the transfer of Ly6C
hi
 monocytes can rescue neurogenesis in antibiotic-




 monocytes sorted from the bone marrow 
into antibiotic-treated mice, two and seven days after discontinuation of antibiotic treatment. 
24 h after the first cell transfer, we started BrdU injections and analyzed the numbers of 
Ly6C
hi
 monocytes as well as proliferating neurons three weeks later. Adoptive transfer of 
isolated bone marrow-derived Ly6C
hi
 monocytes into antibiotic-treated mice significantly 
increased the number of Ly6C
hi
 monocytes in the brain (Figure 3.8B). This rescue was 
paralleled by restored neurogenesis levels in antibiotic-treated mice which received a Ly6C
hi
 
monocyte transfer (Figure 3.8A). However, naïve SPF mice did not benefit from the adoptive 
transfer with respect to the Ly6C
hi
 monocyte population in the brain and hippocampal 
neurogenesis levels. In conclusion, these results confirm that Ly6C
hi
 monocytes are involved 
in the signaling between the periphery and the brain to restore neurogenesis. 
 
 
Figure 3.8: Transfer of Ly6C
hi
 cells into antibiotic-treated animals rescues neurogenesis. 
(A, B) Naïve SPF and antibiotic-treated mice were injected twice with freshly isolated FACS sorted Ly6C
hi
 




 cells in the hippocampus were counted. Two-way ANOVA, Bonferroni post hoc test. ***p<0.001. 
(B) Adoptive transfer of Ly6C
hi 
monocytes increased the number of Ly6C
hi
 monocytes in the brain of Abx treated 
mice, but not in naïve SPF mice. Unpaired two-tailed Student’s t test. *p<0.05, **p<0.01.  
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3.2 Role of monocytes in Alzheimer’s disease 
To investigate the influence of T. gondii induced microglia activation and cell recruitment on 
neurodegenerative diseases, in particular the effect of monocytes and their progeny, we used 
the 5xFAD murine model of AD. After infecting mice with T. gondii, we first analyzed 
cerebral Aβ content, followed by the general immune response and individual cell properties 
at the chronic stage of infection, which is after four to eight weeks of infection. 
3.2.1 T. gondii infection reduces the plaque burden in 5xFAD mice 
We detected that the infection with T. gondii led to reduced plaque burden as determined by 
immunohistological staining of Aβ plaques in 5xFAD mice (Figure 3.9A and A’). 
Quantification revealed significantly lower plaque numbers in the cortex of mice infected 
with T. gondii as compared to transgenic control mice (control 21.9 plaques/mm², T. gondii 
5.9 plaques/mm², p<0.006, Figure 3.9B). This observation was further confirmed by in situ 
two-photon microscopy, which was technically restricted to the observation of cortical layers 
I and II (Figure 3.9C and C’). Here, volumes of the remaining methoxy-X04 stained amyloid 
plaques were significantly reduced in T. gondii infected animals (controls 1548±205µm³, 
T. gondii 466±92µm³, p<0.002, Figure 3.9D). 
While immunohistological methods can only identify Aβ plaques, ELISA measurement 
allows the quantification of total Aβ. Using a sequential protocol, we separated monomeric 
and small oligomeric Aβ (carbonate-soluble) from larger aggregates (guanidine-soluble) in 
whole-brain homogenates. This separation is based on the different solubility of smaller and 
larger aggregates. Smaller aggregates can be dissolved in a rather mild carbonate buffer, 
whereas larger aggregates require a harsh guanidine buffer to be fully dissolved. We 
quantified the amount of Aβ42 and found that it was significantly reduced in both fractions 
(carbonate soluble: control 109.3±21.6 ng/ml, T. gondii 31.1±12.5 ng/ml, p<0.05; guanidine 
fraction: control 406.9±79.9 ng/ml, T. gondii 132.3±35.2 ng/ml, p<0.05, Figure 3.10). 
Using morphological methods, we detected substantial changes in the cortex and subcortical 
regions of infected mice such as inflammatory lesions (Figure 3.11A’), extensive Iba1-
reactivity (Figure 3.11B’) due to the activation of microglia and myeloid cell infiltration, as 
well as GFAP-positive astrogliosis (Figure 3.11C’). Non-infected 5xFAD mice presented with 
known brain histology (Figure 3.11A) and only minor activation of resident glia cells (Iba1 




Figure 3.9: T. gondii infection leads to reduced plaque burden in 5xFAD mice. 
(A, A’) show representative cortex regions with immunohistochemical labeling against Aβ from (A) non-infected 
and (A’) T. gondii infected 5xFAD mice. Arrow heads point towards remaining plaques in infected animals. Scale 
bars represent 1000 µm (left) and 200 µm (right). 
(B) Quantification of cortical Aβ plaques. Data are displayed as mean ± SEM. Significance as determined by 
unpaired t test with Welsh‘s correction is indicated. **p≤0.01. 
(C, C’) Ex vivo two-photon micrographs of the cerebral cortex layers I and II of (C) control and (C’) T. gondii 
infected 5xFAD mice injected with methoxy-X04. Amyloid plaques stained with methoxy-X04 are represented in 
green, autofluorescence is shown in red. One representative z-stack projection spanning at least 50 µm depth is 
shown for each condition. Scale bar, 100 µm. 
(D) Plaque volume in cortical layers I and II determined from at least five ex vivo two-photon micrographs shown 







Figure 3.10: T. gondii infection reduces small and large Aβ aggregates. 
Aβ42 in the carbonate soluble (monomeric and small oligomeric Aβ42 aggregates) and guanidine soluble fractions 
(large Aβ42 aggregates) of whole-brain homogenates was measured by ELISA. Data are presented as mean + 
SEM. Significance levels (p values) determined by unpaired Student’s t test are indicated. *p≤0.05. 
 
Activation of microglia can be recognized by an increased expression of certain surface 
molecules including major histocompatibility complex class (MHC) I and MHC II, CD11c 
and CD45. Flowcytometric analysis revealed a significantly increased expression of these 
markers by brain microglia in T. gondii infected wildtype and 5xFAD mice compared to 
respective non-infected controls (Figure 3.12). For MHC II, CD11c and CD45, genotype did 
not influence expression levels in neither non-infected nor T. gondii infected animals. Mild 
baseline activation of microglia was observed for MHC I, which resulted in an increased 
expression of MHC I by microglia in T. gondii infected 5xFAD animals compared to T. gondii 
infected wildtype mice (Figure 3.12). 
Specific immunodetection for neurons (NeuN labeling) revealed no alterations in the number 
of neurons in the cortex of infected versus control mice (Figure 3.11D, D’). The slightly 
darker shading in the infected brain is due to increased background staining as previously 
seen in this infection model in wildtype C57BL/6J mice (Möhle et al. 2014). Occasionally, 
T. gondii cysts were detectable (Figure 3.11A inset). 
Noting the vast activation of microglia and astrocytes as well as a strong recruitment of 
myeloid cells in the infected animals, we have to potentially take into account additional 
specific and unspecific immunological responses as further factors for the reduction of Aβ 




Figure 3.11: T. gondii infection induces histopathological changes and activation of microglia. 
(A, A’) Hematoxylin and eosin (H&E) stained coronal sections from (A) non-infected and (A’) T. gondii infected 
5xFAD mice. * denotes meningeal infiltrates, arrows show inflammatory foci, the arrow head highlights a T. gondii 
cyst. The inset shows a cyst stained with an antibody against T. gondii. 
(B-D’) Representative pictures of immunohistochemical stainings against (B, B’) Iba1, (C, C’) GFAP, and (D, D’) 
NeuN of coronal brain sections from (B, C, D) non-infected and (B’, C’, D’) T. gondii infected 5xFAD mice. 




Figure 3.12: Microglia are activated in wildtype and 5xFAD mice upon T. gondii infection. 
Mononuclear cells were isolated from wildtype and 5xFAD mouse brains and subjected to flowcytometric analysis. 
Microglia were gated as shown in Figure 3.16 and the surface expression of major histocompatibility complex 
class (MHC) I, MHC II, CD11c and CD45 was quantified using the median fluorescence intensity (MFI) of the 
respective channel. Bars represent mean + SEM. Significance levels (p values) are indicated as determined by 
Fisher’s LSD test. ns, not significant, **p≤0.01, ***p≤0.001, ****p≤0.0001. 
 
3.2.2 Expression of pro- and anti-inflammatory cytokines is triggered by T. gondii 
infection in wildtype and 5xFAD mice 
Collectively, resident and recruited cells form a robust immune response to control T. gondii 
infection by producing pro-inflammatory cytokines, chemokines and anti-parasitic effector 
molecules (Möhle et al. 2014). To characterize this component of the immune response, 
particularly comparing wildtype and 5xFAD T. gondii infected mice, we measured the 
expression of certain cytokines in the brain by semi-quantitative RT-PCR. 
The infection triggered a strongly enhanced mRNA expression of pro-inflammatory 
cytokines, including IFN-γ (wildtype control: 0.23±0.04; wildtype T. gondii: 2011±384; 
5xFAD T. gondii: 2279±95; all values are fold-change over 5xFAD controls), TNF (wildtype 
control: 0.35±0.05; wildtype T. gondii: 201±33; 5xFAD T. gondii: 238±13; all values are fold-
change over 5xFAD controls), IL-1β (wildtype control: 0.37±0.03; wildtype T. gondii: 
183±52; 5xFAD T. gondii: 211±14; all values are fold-change over 5xFAD controls), and IL-6 
(wildtype control: 0.7±0.09; wildtype T. gondii: 22±6; 5xFAD T. gondii: 26±1; all values are 





Figure 3.13: Expression of pro-inflammatory cytokine mRNA in the brain is triggered in T. gondii infected 
wildtype and 5xFAD mice. 
Total RNA was isolated from brains collected from chronically T. gondii infected (n=7) and non-infected control 
(n=5) wildtype and 5xFAD mice. Semi-quantitative RT-PCR was performed for IFN-γ, TNF, IL-1β, and IL-6 and 
relative mRNA levels were normalized on housekeeping gene expression. Data are presented as fold change 
over 5xFAD controls in box and whisker graphs. Significance levels (p values) are indicated as determined by 
unpaired Student’s t test. ns, not significant, ***p≤0.001, ****p≤0.0001. 
 
During chronic T. gondii infection, the pro-inflammatory immune response is followed by the 
production of cytokines associated with anti-inflammatory functions (Gaddi & Yap 2007). In 
this context, we detected increased mRNA expression of IL-10 (wildtype control: 0.85±0.09; 
wildtype T. gondii: 125±19; 5xFAD T. gondii: 148±9; all values are fold-change over 5xFAD 
controls) and TGF-β (wildtype control: 0.52±0.06; wildtype T. gondii: 3.7±0.4; 5xFAD 
T. gondii: 5.1±0.4; all values are fold-change over 5xFAD controls) in T. gondii infected mice 
(Figure 3.14). While IL-10 mRNA expression was independent of the genotype, TGF-β 





Figure 3.14: Expression of anti-inflammatory cytokine mRNA in the brain is triggered in T. gondii infected 
wildtype and 5xFAD mice. 
Total RNA was isolated from brains collected from chronically T. gondii infected (n=7) and non-infected control 
(n=5) wildtype and 5xFAD mice. Semi-quantitative RT-PCR was performed for TGF-β and IL-10 and relative 
mRNA levels were normalized on housekeeping gene expression. Data are presented as fold change over 5xFAD 
controls in box and whisker graphs. Significance levels (p values) are indicated as determined by unpaired 
Student’s t test. ns, not significant, **p≤0.01, ****p≤0.0001. 
 
It is apparent that the immune response triggered by T. gondii causes tremendous changes in 
gene expression profiles. Thus, we wanted to exclude that the reduction of Aβ plaques was 
due to a downregulation of APP which might lead to a diminished production of Aβ42. We 
measured mRNA expression of hAPP in the brains of 5xFAD mice and did not detect 
significant changes compared to non-infected 5xFAD mice (5xFAD T. gondii: 0.64±0.06 
fold-change over 5xFAD controls, p>0.05; Figure 3.15). 
 
 
Figure 3.15: mRNA expression of APP in the brain remains unaltered upon infection with T. gondii. 
Total RNA was isolated from brains collected from non-infected control (n=5) and chronically T. gondii infected 
(n=7) 5xFAD mice. Semi-quantitative RT-PCR was performed for hAPP and the relative mRNA level was 
normalized on housekeeping gene expression. Data are presented as fold change over 5xFAD controls in box 




3.2.3 Recruited monocytes express high CCR2, intermediate TREM2 and CD36 
Local activation of glia cells upon T. gondii infection is accompanied by recruitment of 
immune cells from the periphery to the brain. Among recruited immune cells, the 
CD45
hi CD11bhi myeloid compartment plays an important role in cerebral toxoplasmosis 




neg Ly6Chi monocytes, Ly6Gneg Ly6Cint monocyte-derived DCs and 
Ly6G
neg Ly6Clow monocyte-derived macrophages. In the following, we focused our analysis 
on these three subsets of myeloid-derived CD45
hi CD11bhi Ly6Gneg CCR2+ mononuclear cells 
(gating strategy depicted in Figure 3.16A, A’). These subsets of myeloid cells were chosen 
because age-related defects in the Ly6C
hi
 monocyte population have been linked to cognitive 
decline in a murine AD model (Naert & Rivest 2012a). 
To validate that cell recruitment in 5xFAD mice resembles the cell recruitment observed in 
wildtype mice, we analyzed the relative proportions of Ly6G
neg
 mononuclear cell subsets 







 cells was greatly enhanced compared to respective non-infected 
mice (Figure 3.16A, A’, Figure 3.17). Quantitative analysis revealed no genotype-related 






 mononuclear cells (Figure 3.17). 
Similar to the activation of microglia, these cells can be phenotypically characterized by 
expression of different surface molecules. We were especially interested in phagocytosis-
related molecules, such as TREM2, CD36, and SCARA1. 
To this end, we quantified the MFI by flow cytometry and compared the surface expression 
on resident and myeloid-derived mononuclear cells. The expression pattern was similar for all 
three markers: We found the highest expression of TREM2, CD36 and SCARA1 on 
Ly6C
low F4/80hi macrophages and activated microglia and a lower expression on 
Ly6C
hi CCR2hi monocytes and resting microglia. Ly6Cint mononuclear cells expressed 
intermediate amounts of TREM2, CD36 and SCARA1 on their surface (TREM2: microglia 

























Figure 3.16: Myeloid-derived mononuclear cells are recruited to the brain upon T. gondii infection and 
express phagocytosis related surface molecules. 
Mononuclear cells were isolated from 5xFAD mouse brains and subjected to flowcytometric analysis. 
(A, A’) Representative pseudocolor plots are shown for (A) non-infected and (A’) infected 5xFAD animals and 








 cells to the brain upon T. gondii infection. After 
gating cells by their forward and side scatter properties, excluding doublets and dead cells (not shown), we used 
CD45 and CD11b expression to discriminate between resting microglia (A, bottom elliptic gate) or activated 
microglia (A’, bottom elliptic gate), respectively, and myeloid cells (A’, top elliptic gate). From myeloid cells, Ly6G
+
 











 mononuclear cells. 
(B-E) We compared the surface expression of CCR2, F4/80, TREM2, CD36, and SCARA1 between resting 
microglia, activated microglia and myeloid-derived mononuclear cell subsets. The median fluorescence intensity 
(MFI) for each marker and population is displayed as mean + SEM. Significance levels (p values) determined by 
Fisher’s LSD test are indicated. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001. 
 
Our data indicate that the recruitment of different myeloid-derived mononuclear cell subsets 









 mononuclear cells and Ly6C
low
 macrophages in 
wildtype and 5xFAD mice upon T. gondii infection. 













 mononuclear cell populations were gated as shown in Figure 
3.16. Bars represent the percentage of single cells of each population displayed as mean + SEM. Significance 
levels (p values) are indicated as determined by Fisher’s LSD test. ns, not significant, ****p≤0.0001. 
3.2.4 Myeloid-derived mononuclear cells phagocytose Aβ 
Previous examination of resident and recruited immune cell subpopulations in chronic 
T. gondii infection revealed that these cell subsets display different phagocytic capacity 
(Biswas et al. 2015). Here we compared mononuclear cell subpopulations with respect to their 
ability to specifically phagocytose Aβ42 in an ex vivo phagocytosis assay. To this end, we 
freshly isolated brain mononuclear cells and exposed them to fluorophore-conjugated Aβ42 ex 
vivo. Resident surveilling microglia (CD45
int CD11b+), activated microglia (CD45+ CD11b+) 








were distinguished by flow cytometric analysis. The low ability of resident microglia to take 
up Aβ42 was reflected in their low MFI for Aβ42-HiLyte Fluor 488 (1749±88, Figure 3.18B, 
green bar). Upon T. gondii infection, microglia cells became activated, but their Aβ42 uptake 
remained low (1564±119, Figure 3.18B, blue bar). Notably, Ly6C
hi
 monocytes exhibited the 





 cells were found to exhibit significantly higher MFI 




 3890±387, Figure 
3.18B, medium and light red bars, p<0.0001). Relative MFIs measured in cells isolated from 
wildtype mice showed a similar pattern, confirming that Aβ42 uptake was not restricted to 
5xFAD cells (Figure 3.19). Differences in the absolute values can be – at least in part – 
attributed to the different quantification methods used for both analyses, i. e. conventional 




Figure 3.18: Recruited mononuclear cells are potent Aβ phagocytic cells. 
(A-C) Ex vivo phagocytosis assay was performed with mononuclear cells isolated from 5xFAD and C57BL/6 
mouse brains and cleared from dead cells by sorting via flow cytometer. 
(A) Populations were gated as described in Figure 3.16. Representative histograms show the uptake of 
fluorescence labeled Aβ42 peptide by different cell populations. Gray curves show the 4°C control (dark gray) and 
the Aβ42
-
 control (light gray) for each population. 
(B) Bars indicate the median fluorescence intensity (MFI) of each population to express differences in the amount 
of Aβ42 taken up. Data are displayed as mean + SEM (n=4-5). 
(C) Representative images obtained with FlowSight
TM
 are shown for each population. Scale bar, 20 µm. 




We further verified that the detected fluorescence resulted from internalized Aβ42 rather than 
from unspecific surface-bound signals. Therefore, we analyzed the cells using imaging flow 
cytometry that allows obtaining images of individual cells. Gating was performed as 
described in Figure 3.16A and representative pictures for each population are shown in Figure 
3.18C. Microglia and activated microglia populations contained lower numbers of Aβ+ cells 
(Table 3.1, first column). Consistent with the previous measurements by conventional flow 
cytometry, fluorescence was low or absent in resting and activated microglia, but all 
monocyte populations showed an intense signal (Figure 3.18C and Figure 3.19). Fluorescence 
was distributed equally across the cells, sometimes with several additional bright spots inside 
individual cells. This further indicated the uptake of Aβ42 by recruited mononuclear cells 
(CD45
hi CD11bhi Ly6G- Ly6Chi/int/low) upon T. gondii infection. Morphologically, monocytes 
and the other two monocyte-derived cell subsets were more granular than (activated) 
microglia, represented by higher side scatter intensities (Figure 3.18C and Table 3.1, last 
column). We quantified the internalization of Aβ42 by calculating the ratio of the fluorescence 
intensity within the cell to the intensity of the entire cell. Ratios higher than 0 indicate 
intermediate to high internalization and were found in more than 97% of all Aβ+ cells 
regardless of the population (Table 3.1, second column). The mean internalization varied 
between populations with activated microglia being the lowest and Ly6C
hi
 monocytes being 
the highest (Table 3.1, third column). 
 
Figure 3.19: Quantification of uptake of Aβ42 by imaging flow cytometry. 
The uptake of Aβ42 by different mononuclear cell populations isolated from C57BL/6 wildtype was quantified in an 
ex vivo phagocytosis assay using imaging flow cytometry. Populations were gated as described in Figure 3.16. 
Bars represent the mean fluorescence intensity of each population. Data are displayed as mean + SEM (n=4-5). 




Table 3.1: Quantification of Aβ42 uptake and cell properties by imaging flow cytometry. 




Microglia 77.8±2.5 % 99.3±0.2 % 5.0±0.1 1916±85 
Activated microglia 71.8±2.3 % 97.1±0.2 % 3.0±0.02 1161±35 
Ly6C
hi
 99.4±0.09 % 99.8±0.02 % 5.4±0.06 3574±143 
Ly6C
int
 96.1±0.5 % 99.4±0.1 % 5.0±0.1 3376±130 
Ly6C
low
 92.8±0.8 % 99.0±0.05 % 4.8±0.08 3107±93 
 
To confirm that it is indeed the recruited monocytes and their progeny contributing to plaque 
removal, we ablated Ly6C
hi
 monocytes using a monoclonal anti-CCR2 antibody. We chose a 
lower antibody concentration to only reduce monocyte numbers, because the complete 
elimination would highly increase the susceptibility of infected mice as recently described by 
our research group (Biswas et al. 2015). One week after initiating the ablation, we detected 
significantly reduced Ly6C
hi
 monocyte levels in the blood (Figure 3.20A, B, C). After two 
weeks of anti-CCR2 antibody administration (28 days after infection), Ly6C
hi
 monocyte 
numbers were still significantly reduced in the blood (Figure 3.20B, C). This peripheral 
depletion led to a trending reduction of Ly6C
hi
 monocytes and Ly6C
low
 monocyte-derived 
macrophages in the brain on day 28 after T. gondii infection (Figure 3.20D). From the isolated 
brains, we quantified Aβ42 by ELISA. Importantly, diminished Ly6C
hi
 monocyte numbers 
were associated with an increased total amount of Aβ42 in the brain of T. gondii infected 








 monocytes increases Aβ accumulation in T. gondii infected 5xFAD 
mice. 





 monocytes.  
(A, B) Ly6C
hi
 monocytes in the blood were measured 28 days post infection and after 13 days of anti-CCR2 
administration. Representative dot plots picture the gating strategy and the specific ablation of Ly6C
hi
 monocytes 
in (B) anti-CCR2 treated animals compared to (A) PBS treated animals. 
(C, D) Ly6C
hi
 monocytes in the blood on d22 and d28 as well as in the brain on d28 were analyzed and their 
percentage of live cells is displayed. 
(E) The amount of Aβ42 in the brains of 5xFAD mice after T. gondii infection with and without monocyte ablation 
was measured by ELISA. 
Data (n=4 per group) are presented as mean + SEM. Significance levels (p values) determined by unpaired 
Student’s t test are indicated. *p ≤0.05, **p≤0.01. 
 
3.2.5 Recruited mononuclear cells increase proteolytic clearance of Aβ 
Along with uptake of Aβ, its proteolytic processing is also very important. Therefore, we 
measured the expression of three Aβ-degrading enzymes in the brain, namely insulin-
degrading enzyme (IDE), neprilysin (NEP), and matrix metalloproteinase 9 (MMP9), using 
RT-PCR, and we observed a significant increase in the expression of MMP9 and IDE mRNA 
following infection with T. gondii (MMP9: 1.3±0.1 fold-change over 5xFAD controls, 
p<0.01, Figure 3.21; IDE: 1.7±0.1 fold-change over 5xFAD controls, p<0.01, Figure 3.21). 





Figure 3.21: T. gondii infection enhances mRNA expression of the Aβ degrading enzymes IDE and MMP9. 
Expression of neprilysin (NEP), matrix metalloproteinase 9 (MMP9) and insulysin (IDE) in the brain was measured 
by RT-PCR in non-infected (n=5) and T. gondii infected (n=7) 5xFAD mice. Data are presented as fold-change 
over non-infected 5xFAD mice in box and whisker graphs. Significance levels (p values) determined by unpaired 
Student’s t test are indicated. **p≤0.01. 
We further performed a detailed investigation of brain resident as well as recruited immune 
cells in T. gondii infected mice. Of note, in the chronic stage of infection the intracellular 
parasites form cysts within neurons hiding from the immune system, thus the analyzed cells 
were not directly infected with tachyzoites. We found that MMP9 mRNA was upregulated 
nearly three-fold in activated compared to surveilling microglia, but almost undetectable in 
recruited mononuclear cells (Figure 3.22). IDE mRNA was similarly expressed across all 
innate immune cell populations we investigated (Figure 3.22).  
 
Figure 3.22: mRNA of Aβ degrading enzymes is expressed in different cell populations. 
Expression of MMP9 and IDE by innate immune cells isolated and sorted from the brains of non-infected and 
T. gondii infected C57BL/6 mice was measured by RT-PCR. Each sample consists of pooled cells from 6 animals 
and was measured in triplicates. 
Furthermore, we investigated which cell types are located around the Aβ plaques in the cortex 
of T. gondii infected 5xFAD mice by performing immunofluorescence stainings against Iba1, 
Ly6C, and Aβ. Due to their general distribution in the parenchyma, Iba1+ microglia and 
monocyte-derived macrophages were closely associated with Aβ plaques (Figure 3.23A, B). 
Interestingly, Ly6C
+
 cells were not located directly in the vicinity of Aβ plaques (Figure 
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3.23C, D). As to that, it is important not to confuse Ly6C
+
 monocytes with Ly6C expressing 
endothelial cells (Jutila et al. 1988), which can be recognized by their elongated shape. This 
qualitative finding was confirmed by quantification of fluorescence intensity around plaques 
(Figure 3.24A, B). 
 
Figure 3.23: Microglia but not Ly6C
hi
 monocytes are located in the vicinity of Aβ plaques. 
Immunolabeled coronal sections from T. gondii infected 5xFAD mice. 
(A, B) Co-labeling of Iba1 (microglia) and Aβ (plaques) reveals close interaction of microglia with plaques. (A) Low 
magnification (20x) overview of the cortex. Scale bar, 200 µm. (B) Representative cortical plaque surrounded by 
microglial processes. 63x magnification, scale bar, 20 µm. 
(C, D) In sections co-labeled for Ly6C (Ly6C
hi
 monocytes) and Aβ (plaques), Ly6C
hi
 monocytes were not located 
in the direct vicinity of plaques. (C) Low magnification (20x) overview of the cortex. Scale bar, 200 µm. 
(D) Representative cortical plaque with a nearby Ly6C
+
 blood vessel but no associated Ly6C
hi
 monocytes. 63x 
magnification, scale bar, 20 µm. 
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 mononuclear cells are 
highly capable of removing soluble Aβ peptides. While Ly6Chi monocytes contribute 
significantly to this clearance, they cannot be found in the direct vicinity of established 
plaques and thus, may rather lower the general amount of Aβ to prevent higher molecular 
weight Aβ aggregates and plaque formation. 
 
Figure 3.24: Iba1 but not Ly6C reactivity is increased around Aβ plaques 
(A, B) Immunolabeled coronal sections from T. gondii infected 5xFAD mice were analyzed to quantify the 
fluorescence intensity of (E) Iba1 and (F) Ly6C in the direct environment of plaques. The black line represents the 




3.2.6 T. gondii infection reduces Aβ load in older animals 
In the previously described experiments, mice were infected around the time point when first 
plaques become detectable in the brain (60 d). Additionally, we were interested whether in 
older animals the Aβ burden can also be reduced by T. gondii infection. Therefore, we 
infected 7 months old 5xFAD mice and used ELISA to quantify Aβ. After 6 weeks of 
infection, we found a significantly lower amount of Aβ in the brains of T. gondii infected 
compared to non-infected 5xFAD mice (control 7529±623 ng/ml, T. gondii 4641±487 ng/ml, 
p<0.001, Figure 3.25). 
 
 
Figure 3.25: Infection with T. gondii reduces total Aβ burden in older animals. 
The amount of Aβ42 in the brains of aged (7 months) non-infected and T. gondii infected 5xFAD mice was 
measured by ELISA on d44 post infection. The significance level (p value) determined by unpaired Student’s t test 





4.1 Role of monocytes in neurogenesis within the gut-brain-axis 
In the first part of this study, we examined the interactions between antibiotic treatment, 
intestinal microbiota and adult hippocampal neurogenesis. 
Treatment with antibiotics severely depleted the intestinal microbiota and was associated with 
reduced levels of proliferating cells in the hippocampus of mice. Reconstitution of the 
intestinal flora with probiotics rescued neurogenesis in antibiotic-treated mice. Similarly, a 
recent study conducted in a mouse model of stress has also found probiotics to increase 
neurogenesis levels (Ait-Belgnaoui et al. 2014). Like probiotics, voluntary exercise improved 
neurogenesis in antibiotic-treated mice to naïve SPF levels in our experiments. This is 
consistent with previous experimental setups where physical exercise is a widely used 
strategy known to promote neurogenesis in various disease models (Kempermann et al. 2010; 
van Praag et al. 1999; Wolf et al. 2011; Farioli-Vecchioli et al. 2014). 
Interestingly, both treatment paradigms were accompanied by an increase of the Ly6C
hi
 
monocyte population in the brain. Previous findings indicate that CCR2
+ Ly6Chi monocytes 
entering the CNS are essential for recovery after spinal cord injury (Shechter et al. 2009) and 
potentially contribute to restrict cerebral amyloidosis (Naert & Rivest 2013). These results 
propose new beneficial roles in addition to the established pro-inflammatory one (Biswas et 
al. 2015; Hammond et al. 2014; Karlmark et al. 2012). With respect to neurogenesis, previous 
reports have linked cells of the adaptive immunity i. e. T cells to the maintenance of this 
homeostatic process (Ziv et al. 2006; Wolf et al. 2009). 
Investigating the potential link between Ly6C
hi
 monocytes and neurogenesis in more detail, 
we demonstrated that the lack of Ly6C
hi
 monocytes, either by knockout of CCR2 or by 
antibody-induced depletion, led to decreased hippocampal neurogenesis levels. Moreover, 
substitution of antibiotic-treated mice with adoptively transferred Ly6C
hi
 monocytes was also 
able to rescue neurogenesis. 
Unexpectedly, the fecal transplant from naïve SPF into antibiotic-treated mice could not 
rescue neurogenesis and Ly6C
hi
 monocyte numbers. Even though the SPF transplant seemed 
to promote a microbiome similar to that of naïve SPF mice, it cannot be excluded that the 
treatment induced fine-tuned robust changes as described for human subjects (Lozupone et al. 
DISCUSSION 
65 
2012). Alternatively, these data suggest a (partial) direct and long-lasting effect of antibiotics 
on the host which is not mediated by the intestinal microbiota. Indeed, a recent study 
confirmed that at least two factors are responsible for antibiotic-induced changes in gene 
expression, depletion of microbiota and direct interaction with host tissues (Morgun et al. 
2015). The authors argue that, as host mitochondria have retained many features of bacteria 
from which they descend, this similarity may actually facilitate the direct interaction between 
antibiotics and cell metabolism (Morgun et al. 2015). However, both adoptive transfer of 
Ly6C
hi
 monocytes and voluntary exercise were able to increase neurogenesis in antibiotic-
treatment mice, indicating that neurogenesis was not irreversibly impaired and that it is 
possible to overcome the potential direct effects of antibiotics using appropriate stimuli. From 
these results we concluded that not the lack of intestinal flora as such determines neurogenesis 
levels, but that there is a common regulator or messenger, mediating signals from the 
periphery to the brain and that this mediator is affected by antibiotic and probiotic treatment 
and exercise. Considering the results presented here as well as the finding that Ly6C
hi
 
monocytes can support neurosphere formation in vitro (data not included in this thesis), we 
suggest Ly6C
hi
 monocytes as a potential mediator. 
As Ly6C
hi
 monocytes migrate via the bloodstream from the bone marrow to their destined 
location, we investigated their presence in both tissues. We revealed that antibiotic-induced 
depletion of microbiota reduces Ly6C
hi
 monocyte numbers in the bone marrow. In line with 
our results, several studies have reported the substantial impact of microbiota on host 
immunity including their ability to regulate myeloid hematopoiesis in the bone marrow (Hill 
et al. 2012; Deshmukh et al. 2014). This effect is manifested in a reduced bone marrow-
derived monocyte population in the spleen of germ-free mice (Khosravi et al. 2014). 
Subsequently, antibiotic treatment also reduced the number of Ly6C
hi
 monocytes in the blood. 
Four weeks after discontinuation of antibiotic treatment, both bone marrow and blood 
populations had recovered, but the reduced number of Ly6C
hi
 monocytes in the brain was still 
evident. We presume that this is due to the slow turnover rate of peripheral immune cells in 
the brain as it has been previously described for leukocytes (Ousman & Kubes 2012). 
We found no changes of the numbers of microglia, the brain’s intrinsic immune cell 
population, upon any of the treatments. This finding is consistent with a recent study in germ-
free mice (Erny et al. 2015). Despite unchanged cell numbers, Erny and colleagues describe 
alterations of morphology and phenotypic marker expression (Erny et al. 2015). However, it 
is unclear whether these modifications also occur upon antibiotic treatment as the absence of 
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microbiota during the entire ontogenesis (in germ-free mice) has more pronounced effects 
than short-term absence (due to antibiotic treatment), such as impaired brain and immune 
system development (Mazmanian et al. 2005; Abt et al. 2012; Diaz Heijtz et al. 2011; Cryan 
& Dinan 2012). As the study by Erny et al. investigated only microglia and missed the 
important contribution of myeloid-derived cells, a direct comparison of our results to this 
study is rather difficult. It is likely that some of the changes reported in germ-free mice could 
be attributed to alterations in the circulating immune cell composition and function. 
This basic difference between the two models became further obvious when we quantified 
neurotrophic factors and did not find differences with respect to BDNF and NGF mRNA 
expression. In contrast, germ-free mice present with increased BDNF mRNA levels in the 
hippocampus (Neufeld et al. 2011) and decreased BDNF mRNA levels in the amygdala 
(Arentsen et al. 2015). Increased neurogenesis found in germ-free mice (Ogbonnaya et al. 
2015) would correspond to the increased BDNF expression (Neufeld et al. 2011) as well as 
increased motor activity in this model (Diaz Heijtz et al. 2011). Another study reported 
reduced BDNF mRNA levels in the adult hippocampus after early depletion of intestinal 
microbiota from weaning onwards (Desbonnet et al. 2015). Thus, it becomes apparent that 
differences between our model and the germ-free model make it difficult to compare these 
studies. 
CCR2
+ Ly6Chi monocytes were located mostly in the choroid plexus and only in rare cases in 
the hippocampus. The remote distance of Ly6C
hi
 monocytes from the proliferating neuronal 
precursors indicates that it is probably soluble factors which mediate this interaction. We 
could not identify a concrete mechanism, but our results suggest that BDNF, NGF, TNF and 
IL-6 are not involved, even though they have all been shown to influence neurogenesis (Iosif 
et al. 2006; Scharfman et al. 2005; Rossi et al. 2006; Frielingsdorf et al. 2007; Islam et al. 
2009). It also remains to be investigated whether this regulation has a direct effect on 
proliferating precursors or it indirectly modulates the neurogenic niche. 
Taken together, our results demonstrate that antibiotic treatment results in a long lasting 
impairment of neurogenesis, which can be reversed by probiotics and exercise. Ly6C
hi
 
monocytes, a myeloid-derived innate immune cell population, critically contribute to this 
restoration. While we cannot completely rule out the contribution of other CNS resident cells, 
our analysis of Ly6C
hi
 monocytes in different treatment paradigms in conjunction with the 
depletion and re-substitution experiments point toward their crucial involvement in 
maintenance of adult hippocampal neurogenesis. Among the multiple factors forming the gut-
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immune-brain-axis, we highlight the synergy between intestinal flora and Ly6C
hi
 monocytes 
as one potential route of communication. Finally, our results provide a rationale for probiotic 
supplementation and exercise to restore monocyte homeostasis and brain plasticity as 
countermeasure against the side effects of prolonged antibiotic treatment. 
4.2 Role of monocytes in Alzheimer’s disease 
In the second part of this study, we investigated the effect of the commonly persisting cerebral 
Toxoplasma infection and resulting CNS inflammation on Aβ plaque formation in a murine 
model of AD. In the following, I will first discuss the etiologic connection between T. gondii 
and AD and how our results contribute to the understanding of this connection. Second, I will 
address the individual results and evaluate what we learned from this experimental setup with 
respect to a possible treatment of AD. 
4.2.1 Etiologic connection between T. gondii and AD 
Aβ and hyperphosphorylated tau form disease promoting aggregates in AD that trigger 
chronic cerebral inflammatory processes (Hickman et al. 2008; Meda et al. 1995). Further 
modulation of the chronic inflammation may occur following several infectious diseases, 
which are known to induce inflammatory cascades in the CNS. It is well established that 
certain pathogenic components modulate the course of disease in murine β-amyloidosis 
models (Kahn et al. 2012). Although the impact of particular infections during the 
pathogenesis of AD has been discussed, the underlying mechanisms are especially 
challenging to untangle (reviewed in Miklossy 2011). Periodontal infections have been found 
to increase the Aβ load in vulnerable brain areas in non-AD humans (Kamer et al. 2015). The 
respiratory pathogen Chlamydia pneumoniae is more present in human AD patients (Balin et 
al. 1998) and is also able to induce Aβ plaques in wildtype mice (Little et al. 2004). In 
general, previous studies have found chronic or latent infections to be associated with an 
increased risk for AD (reviewed in Miklossy 2011), although evidence regarding T. gondii 
specifically is inconclusive (Kusbeci et al. 2011; Perry et al. 2015). On the other hand, in a 
recent study using a mouse model of cerebral β-amyloidosis, T. gondii infection has been 
associated with a reduced risk of developing AD-like pathology (Jung et al. 2012). Our study 
provides further evidence for this notion, as we detected a significant reduction in the number 




Despite this observed reduction in plaque deposition, one should be cautious in concluding 
that T. gondii infection may protect against developing AD. In fact, while evidence regarding 
actual disease risk is sparse and conflicting (Kusbeci et al. 2011; Perry et al. 2015), latent 
toxoplasmosis in healthy individuals has recently been associated with subtle reductions of 
cognitive performance in various tasks (Gajewski et al. 2014; Shawn D. Gale et al. 2015; S D 
Gale et al. 2015). Directly translating this finding to the situation of human AD patients is 
rather difficult, considering the limitations of the applied experimental model. Low dose 
infection of mice with the parasite is a broadly used model to mimic human chronic 
Toxoplasma infection (Parlog et al. 2014; Möhle et al. 2014; Biswas et al. 2015; Nance et al. 
2012; Z. T. Wang et al. 2015; Blanchard et al. 2015; Gulinello et al. 2010; Haroon et al. 2012; 
Hermes et al. 2008), although the immune cell recruitment in mice is most likely more 
pronounced than during latent chronic infection of humans. Considering that we propose the 
recruited immune cells as major mediators of the beneficial effect, it is unclear which effects 
are applicable to the human CNS. 
4.2.2 Insights regarding the treatment of AD 
As mentioned above, we measured decreased levels of Aβ plaques in the brains of T. gondii 
infected 5xFAD mice and the remaining plaques were also smaller in volume. These findings 
are consistent with the aforementioned study by Jung and colleagues, where they further 
described an improved performance in behavioral tests compared to non-infected transgenic 
mice (Jung et al. 2012). 
We performed a more detailed investigation of the Aβ load and detected that the general 
reduction of Aβ plaques was paralleled by a decrease in small soluble Aβ species. Because 
higher levels of soluble Aβ has previously been linked to decreased cognitive performance 
(Zhang et al. 2011; Lesné et al. 2008), this finding suggests that our experimental setup at 
least partially protects from cognitive decline. 
Before studying the direct contribution of immune cells, we outlined the immune response in 
the brain. We measured increased levels of IFN-γ, TNF, IL-1β, IL-6, IL-10 and TGF-β mRNA 
in T. gondii infected wildtype and 5xFAD mice compared to respective controls. IFN-γ is the 
key cytokine controlling T. gondii infection (Wang et al. 2004; Wang et al. 2005), but also 
TNF, IL-1β and IL-6 carry out important anti-parasitic effector activities (Jebbari et al. 1998; 
Schlüter et al. 2003; Hunter et al. 1995). Increased IL-10 and TGF-β have been described to 
counterbalance the inflammation and thus, prevent extensive tissue damage in chronic 
T. gondii infection (Wilson et al. 2005; Cekanaviciute et al. 2014). Interestingly, in addition to 
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its involvement in the immune reaction against T. gondii, IL-6 has been found to induce 
phagocytic markers and therefore reduce Aβ deposition (Chakrabarty et al. 2010). Overall, the 
significant changes in cytokine mRNA expression are attributed to the infection and not the 
mouse genotype. Despite the broad changes in inflammatory gene expression, APP expression 
remained unaltered in T. gondii infected 5xFAD mice compared to non-infected controls and 
cannot account for the reduced plaque burden. 
Curiously, in the study by Jung and colleagues, the authors did not measure elevated IFN-γ 
levels in T. gondii infected Tg2576 mice despite using the same parasite strain as we did and 
an even higher infection dose (Jung et al. 2012). With respect to the experimental setup, the 
main difference between their study and ours is the mouse model. Due to only one genetic 
mutation, Tg2576 mice start to develop plaques only at the age of 9 months (Chin 2011), 
while the 5xFAD mice used by us already show plaque deposition starting from the age of 2 
months (Chin 2011; Fröhlich et al. 2013). This faster progression allows for shorter 
experiment times, but both transgenic models are based on the C57BL/6 background (Chin 
2011) and thus, show a high susceptibility to the infection with T. gondii compared to other 
mouse strains like Balb/c (Dupont et al. 2012). 
Consequently, our histopathological evaluation revealed substantial changes in both cortical 
and subcortical brain regions of infected mice, indicating the infiltration by immune cells 
(monocytes and lymphocytes) and the pronounced activation of resident microglia and 
astrocytes. These observations point toward a functional role for resident and recruited 
immune cells in reducing the Aβ burden. 
Controlling the infection with T. gondii requires the collaboration of innate and adaptive 
immunity (Dupont et al. 2012). Even though there are inflammatory diseases of the CNS 
which involve adaptive immune cells, such as multiple sclerosis, the inflammation observed 
in AD seems to be restricted to innate immune cells (Heppner et al. 2015). Thus, we focused 
our further analysis on the contribution of the innate compartment. 
The detailed analysis of infiltrating immune cells confirmed the strong recruitment of innate 
immune cells, particularly CD45
hi CD11bhi myeloid cells, to the brains of T. gondii infected 
5xFAD mice, similar to that seen in wildtype mice. It has been described previously by our 
group that in mice chronically infected with T. gondii, Ly6Chi monocytes migrate to the CNS 
and further differentiate into Ly6C
int
 mononuclear cells and Ly6C
low 
macrophages in order to 
carry out specific tasks in host defense, such as cytokine production and Fc receptor mediated 
cellular phagocytosis (Biswas et al. 2015; Möhle et al. 2014). 
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We analyzed the contribution of these myeloid-derived mononuclear cell subsets in the 
process of accumulating Aβ plaques that, according to the widely accepted view on AD 
pathophysiology, ultimately promote neurodegeneration. 
Ex vivo phagocytosis assay most likely by an antibody-independent mechanism revealed that 
all recruited mononuclear subpopulations were able to take up significantly more Aβ42 than 
microglia from non-infected or activated microglia from T. gondii infected 5xFAD mice. We 
found that Ly6C
hi
 monocytes displayed an even higher uptake compared to Ly6C
low
 cells. 
Comparing the ability to take up Aβ42 with the ability to take up latex spheres as previously 





subsets. While their uptake of latex spheres is very low (Biswas et al. 2015), they displayed a 
prominent uptake of Aβ42. Even though our results are against the general view that Ly6C
low
 
cells are the most macrophage-like subset, other publications have attributed phagocytic 
activity to Ly6C
+
 monocytes against parasites (Sponaas et al. 2009; Sheel & Engwerda 2012). 
Thus, we conclude that uptake of latex beads and Aβ42 is mediated by different mechanisms 
with diverse appearance in Ly6C
hi
 monocytes and Ly6C
low
 macrophages. 
While neuroinflammation has been conventionally reported to be detrimental and associated 
with several neurological diseases (London et al. 1996; Akiyama et al. 2000; Lyman et al. 
2013), emerging research promotes a more differentiated view on the roles of recruited 
immune cells in homeostatic and repair mechanisms (Shechter et al. 2009; Ziv et al. 2006; 
Frenkel et al. 2005; Pahnke et al. 2013; Fröhlich et al. 2013). Consistent with this concept, 
there are a growing number of reports indicating the beneficial effect of recruited immune 
cells in AD and vascular amyloidosis (Simard et al. 2006; Naert & Rivest 2012b; El Khoury 
et al. 2007; Hawkes & McLaurin 2009; Michaud et al. 2013; Koronyo et al. 2015). 
Performing the ex vivo phagocytosis assay with cells obtained from both wildtype and 5xFAD 
mice, we also observed that the relative contributions were independent of the genotype, 
despite absolute values being different. As these differences were most likely caused by the 
different quantification methods, we conclude that wildtype cells are potent Aβ clearing cells 
as well. Importantly, this finding suggests that cells probably do not have to be pre-exposed to 
Aβ to efficiently phagocytose Aβ in a possible treatment strategy. It is somehow challenging 
that human macrophages were found to be ineffective at Aβ phagocytosis when derived from 
AD patients (Fiala et al. 2005). Nevertheless, modulating the route of entry may provide a 
tool to skew recruited monocytes towards an inflammation resolving phenotype (Schwartz & 
Baruch 2014) and the capacity of these manipulated monocytes to remove Aβ remains to be 
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investigated, as two studies have found that the replacement of brain resident microglia with 
peripheral myeloid cells does not reduce the Aβ burden (Prokop et al. 2015; Varvel et al. 
2015). Both studies used a similar approach to replace microglia with peripheral cells, i. e. 
depletion of brain resident CD11b-expressing cells during a 10 to 14 days intracerebral 
ganciclovir treatment of CD11b-HSVTK (herpes simplex virus thymidine kinase) transgenic 
mice (Prokop et al. 2015; Varvel et al. 2015). This treatment leads to a one-time replacement 
with bone marrow-derived myeloid cells, as opposed to the continuous influx observed in our 
model of chronic cerebral T. gondii infection. Additionally, Prokop and colleagues point out 
the lack of an activating stimulus in their model, which would be able to induce the uptake of 
Aβ by myeloid cells (Prokop et al. 2015). Even though this lack of stimulation is resolved in 
our experimental model, finding appropriate stimuli to manipulate the cells is a complex task, 
as we have to keep in mind that beneficial and detrimental effects of monocytes and 
macrophages can occur at the same time (Gensel et al. 2009). 
The increased amount of Aβ42 detected following CCR2
hi Ly6Chi monocyte ablation in 
infected 5xFAD mice points to a causal role of these cells to Aβ clearance. Our findings are 




low CCR2+ Gr1+) monocytes to cognitive decline in APPSwe/PS1 mice (Naert & 
Rivest 2012a). This hypothesis is further strengthened by two recent studies where myeloid 
cell recruitment to the CNS was correlated with Aβ plaque reduction (Koronyo et al. 2015; 
Hohsfield & Humpel 2015). In a very recently published study, Baruch and colleagues 
proposed a novel treatment strategy to target AD via programmed death-1 (PD-1) inhibition 
and thereby increasing the recruitment of Ly6C
hi
 monocytes to the CNS in an IFN-γ 
dependent manner (Baruch et al. 2016). The proposed mechanisms included enhanced cellular 
uptake and degradation. Furthermore, Savage et al. detected phagocytic cells directly 
associated with plaques, and the CD45
hi
 status of these cells suggested their myeloid origin 
(Savage et al. 2015). Only short-term recruitment of monocytes did not alter plaque 
deposition as seen in a mouse model of traumatic brain injury (Collins et al. 2015). 
Having confirmed Ly6C
hi
 monocytes as key contributors to Aβ removal in our model, we 
were interested if they migrate into the parenchyma to “attack” Aβ plaques like previous 
reports have shown (Mildner et al. 2011; Simard et al. 2006; Hohsfield & Humpel 2015). 
However, CCR2
+ Ly6C+ monocytes were not located in the vicinity of plaques in our 
experiments. Therefore, we propose that the low plaque burden in the applied experimental 
model is due to Ly6C
hi
 monocytes’ increased capacity to remove soluble Aβ rather than due 





upregulate F4/80 and Iba1, and can be located adjacent to the plaques, similarly to resident 
microglia. 
It has to be carefully investigated, at which stages of disease the recruitment of monocytes 
and subsequent removal of Aβ is beneficial and can delay the onset of disease, and at which 
stages the cascade triggered by Aβ is already on its way and additional cell recruitment 
potentially worsens neuroinflammation (Musiek & Holtzman 2015). Our data from old 
animals provides evidence that the ability of freshly recruited immune cells to remove Aβ 
persists at later stages of experimental amyloidosis. 
Searching for a mechanism mediating Aβ uptake, we analyzed the expression of cell surface 
markers related to phagocytosis on CD11b
hi Ly6G- myeloid-derived cells. The measurements 
revealed intermediate levels of TREM2, CD36 and SCARA1 on Ly6C
hi
 monocytes and high 
levels on Ly6C
low
 monocyte-derived macrophages. Recent reports of a correlation between 
genetic TREM2 mutation and AD (Jonsson et al. 2013; Guerreiro et al. 2013), along with 
experiments pointing out the anti-inflammatory and phagocytosis-enhancing role of TREM2, 
have drawn the attention towards this molecule (Jones et al. 2014; Jiang et al. 2013; Cantoni 
et al. 2015; Y. Wang et al. 2015). We detected that monocyte-derived Ly6C
low
 macrophages 
expressed high levels of TREM2, in contrast to Ly6C
hi
 monocytes. This result underlines that, 
besides TREM2, other factors may determine the capacity of immune cells such as monocytes 
to phagocytose Aβ. Several studies have suggested that CD36 expression is associated with 
Aβ uptake (Yamanaka et al. 2012; Koenigsknecht & Landreth 2004; Hickman et al. 2008), 
consistent with the CD36 expression of Ly6C
low
 monocyte-derived macrophages. Moreover, 
the lower expression of CD36 detected on Ly6C
hi
 monocytes may be beneficial because of 
less harmful pro-inflammatory CD36-Aβ interaction (Kagan & Horng 2013; Frenkel et al. 
2013; Moore et al. 2002; Wilkinson & El Khoury 2012). Frenkel and colleagues had shown 
that SCARA1 (and not CD36) mediates phagocytosis of Aβ (Frenkel et al. 2013). However, 
similar to TREM2 and CD36, SCARA1 expression was not a reliable predictor of the Aβ 
phagocytic capacity of each myeloid-derived mononuclear cell subset in our model. 
Recent research highlights the importance of proteolytic Aβ degradation. Several enzymes are 
known to digest Aβ, including MMP9 and IDE, but the contribution of each enzyme is 
crucial. Removal of only one can result in significantly increased cerebral Aβ levels (Saido & 
Leissring 2012), and overexpression leads to decreased Aβ loads (Leissring et al. 2003; 
Hoshino et al. 2011; Saido & Leissring 2012). We found both MMP9 and IDE upregulated 
significantly upon T. gondii infection in 5xFAD mice. 
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MMP9 is one of several matrix metalloproteinases that have been implicated in Aβ 
degradation and administration of an MMP inhibitor resulted in increased Aβ loads (Saido & 
Leissring 2012). Activation of MMPs has to be regarded carefully as well, as a recent study 
has shown that Aβ increases the permeability of the BCSFB by activation of MMPs (Brkic et 
al. 2015). Even though Brkic and colleagues found the biggest changes for MMP3 expression, 
the contribution of other MMPs cannot be ruled out. IDE has several substrates and exists as a 
cytosolic, membranous, and secreted variant (Wang et al. 2006), which can be ubiquitously 
found in human tissue including immune cells like granulocytes (Weirich et al. 2008). It 
hydrolytically cleaves Aβ (Mukherjee et al. 2000), and the significantly increased expression 
of IDE, particularly in conjunction with the simultaneously increased MMP9 expression, 
therefore most likely promoted the enhanced degradation of Aβ in T. gondii infected 5xFAD 
mice, when compared to non-infected controls. Upregulation of IDE may be a compensatory 
mechanism, since insulin has been shown to stimulate the growth of T. gondii in vitro (Zhu et 
al. 2006), and increased Aβ degradation could be a beneficial secondary effect. An interesting, 
yet unanswered question is whether IDE family members expressed by T. gondii itself 
(Laliberté & Carruthers 2011) could also contribute to Aβ degradation. Their substrates are, 
however, not currently known, although structural analysis suggests that T. gondii IDEs may 
be different from other family members (Hajagos et al. 2012). 
In addition, intracellular control of protein homeostasis is mediated by the ubiquitin-
proteasome system (UPS), whereby proteasomes represent the proteolytically active part. 
Dysfunction of the UPS has been shown to be an early event in AD, suggesting that 
proteasomes may be unable to properly degrade ubiquitin-tagged proteins (Dantuma & Bott 
2014). Immunoproteasomes are specific proteasome isoforms that have incorporated 
immunosubunits instead of the conventional proteases. Data not included in this thesis (Möhle 
et al. 2016) suggest a possible involvement of the immunoproteasome in Aβ degradation 
particularly by monocytes. The exact engagement of the UPS in the mentioned processes still 
requires detailed investigation in forthcoming experiments. 
Taken together, our results demonstrate that mononuclear cell recruitment to the brain upon 
chronic T. gondii infection leads to reduced plaque burden by promoting phagocytosis of 
soluble Aβ42 and enhanced proteolytic degradation. This aspect is especially critical in a 
situation where resident microglia are dysfunctional and fail to control amyloid plaque 
deposition (Hickman et al. 2008; Orre et al. 2014). Chronic T. gondii infection acts as a strong 
immunological stimulus, possibly even overcoming the impaired phagocytic capacities of 
monocytes/macrophages as observed in AD patients (Fiala et al. 2005). In the light of a future 
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treatment option, a recent study by Neal and Knoll presented data from mice showing that 
infection with T. gondii protects from bacterial infection with Listeria monocytogenes by 
recruitment of Ly6C
hi
 monocytes. Further experiments revealed that only application of a 
component of T. gondii is sufficient to mediate the resistance (Neal & Knoll 2014). This 
method of recruiting monocytes may be interesting to consider, as our results suggest a 
promising candidate mechanism for the protective effect, namely increased phagocytosis and 
degradation of Aβ. 
4.3 Conclusions 
With two distinct experimental setups I could demonstrate that Ly6C
hi
 monocytes 
significantly contribute to brain homeostasis, in addition to their well-established roles in 
inflammatory and infectious conditions. I have presented evidence that they link changes in 
neurogenesis to an altered gut flora and physical exercise, and that they are also highly potent 
Aβ removing cells. As discussed above, these findings add to an increasing body of work 
which focusses on the beneficial effects of monocytes and possible therapeutic applications. 
Although the experiments presented in this thesis were conducted exclusively in mouse 
models, the results open the door for subsequent studies with human subjects. 
While my thesis has focused on one particular subset of innate immune cells, the immune 
system is extremely complex and new types of immune cells are still being discovered e. g. 
certain ILCs have emerged only in the past years. Thus, it is very likely that future research 
will discover more diverse roles for other immune cell types.  
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